Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024474	li-alb	mg/l (mg/l)	3033	3252	0.00%
3024474	li-alb	— (—)	465	492	100.00%	Distribution not available
3024474	li-alb	g/l (mg/l)	33	34	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

1205

1728

3.85

322.01

1.1

253.14

275.05

mg/l

1.19

1055

1522

Autoimmune diseases excluding thyroid diseases, strict definition

1175

1684

3.87

316.18

1.1

253.83

276.81

mg/l

1.24

1028

1482

Other and unspecified polyneuropathies, also in other diseases

358

363

10.26

314.75

1.1

319.65

294.98

mg/l

0.81

328

310

Neurological diseases

1117

507

11.26

307.65

1.1

1.0

242.12

236.93

mg/l

0.20

978

445

MS-disease / Multiple Sclerosis

606

192

38.85

307.65

1.1

213.80

226.94

mg/l

0.68

528

165

Visual disturbances and blindness

737

1459

5.16

307.65

1.1

265.42

258.18

mg/l

0.15

659

1287

Disorders of optic nerve and visual pathways

352

276

13.86

307.65

1.1

1.0

244.84

240.09

mg/l

0.06

301

243

Abnormal findings on diagnostic imaging of central nervous system

286

109

30.55

307.65

1.1

249.60

239.87

mg/l

0.18

247

Other symptoms and signs involving the nervous and musculoskeletal systems

848

1052

8.34

307.65

1.1

244.22

251.15

mg/l

0.35

732

939

Visual disturbances

708

1373

5.28

307.65

1.1

264.00

256.92

mg/l

0.14

635

1205

Demyelinating diseases of the central nervous system

717

237

37.17

307.65

1.1

215.66

236.27

mg/l

1.10

633

205

Postprocedural disorders of nervous system

312

230

14.93

307.65

1.1

1.0

210.32

227.86

mg/l

0.52

272

194

Neurological diseases, wide definition

501

100

25.70

307.65

1.1

238.22

207.26

mg/l

1.30

435

Autoimmune diseases related-to ILD

1055

2317

3.95

307.65

1.1

230.07

280.97

mg/l

7.11

913

2046

Symptoms and signs involving the nervous and musculoskeletal systems

1122

1423

8.14

307.65

1.1

258.10

271.71

mg/l

0.71

969

1271

Other degenerative diseases of the nervous system

835

135

48.78

307.65

1.1

1.0

228.70

257.66

mg/l

0.65

733

116

Other demyelinating diseases of the central nervous system

367

50.61

307.65

1.1

210.38

228.39

mg/l

0.57

323

Disturbances of skin sensation

675

889

7.93

307.65

1.1

229.93

250.28

mg/l

0.86

600

777

Polyneuropathies and other disorders of the peripheral nervous system

412

430

9.96

307.65

1.1

340.72

288.35

mg/l

2.20

377

368

Optic neuritis

235

125

21.62

304.59

1.1

1.0

205.57

218.81

mg/l

0.58

200

106

Headache

841

1576

4.33

300.23

1.1

246.93

259.37

mg/l

0.37

736

1394

Symptoms and signs involving the skin and subcutaneous tissue

861

2148

3.99

293.65

1.1

249.00

267.25

mg/l

0.73

759

1884

Other neurological diseases

799

1483

4.30

281.29

1.1

272.02

284.31

mg/l

0.30

697

1310

ILD medications: immunosuppressive drugs

761

1868

3.84

243.21

1.1

241.34

281.68

mg/l

3.30

655

1649

Concussion

361

373

7.97

241.29

1.1

1.0

257.99

236.16

mg/l

0.42

310

330

Intracranial trauma

388

385

7.15

220.65

1.1

1.0

257.73

233.92

mg/l

0.51

337

340

Autoimmune diseases

1088

1736

3.22

220.53

1.1

250.64

274.73

mg/l

1.39

963

1528

Encephalitis

148

25.20

205.12

1.3

1.1

328.91

233.03

mg/l

3.02

138

Used for control exclusion in common control thyroid runs

1012

1613

3.20

202.93

1.1

252.45

276.76

mg/l

1.28

894

1422

Symptoms and signs involving cognition, perception, emotional state and behaviour

968

2182

3.06

199.68

1.1

261.53

266.08

mg/l

0.16

856

1910

Other encephalitis

141

25.61

196.50

1.2

1.1

334.93

233.11

mg/l

3.12

131

Abnormalities of gait and mobility

206

189

11.32

194.26

1.1

320.18

294.20

mg/l

0.51

170

165

General symptoms and signs

1024

1685

3.07

192.24

1.1

255.89

264.16

mg/l

0.28

900

1490

ILD medications

1101

2100

2.87

189.70

1.1

240.01

273.93

mg/l

3.15

966

1845

Diplopia

240

283

8.81

188.23

1.1

339.01

277.71

mg/l

0.56

213

236

Other symptoms and signs involving cognitive functions and awareness

438

861

4.70

181.38

1.1

283.42

288.22

mg/l

0.08

389

750

Subjective visual disturbances

347

659

5.39

172.74

1.1

250.84

259.24

mg/l

0.11

320

577

Inflammatory diseases of the central nervous system

203

227

9.43

166.50

1.2

1.1

370.96

274.76

mg/l

2.52

184

193

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

587

1526

3.48

161.44

1.1

265.13

288.19

mg/l

1.10

512

1346

Malaise and fatigue

470

957

4.00

152.73

1.1

260.54

271.69

mg/l

0.41

411

850

Spirochaetal infections, other/unspecified

182

201

9.50

150.62

1.1

375.49

274.76

mg/l

3.60

173

175

Use of teriflunomide

38.83

142.58

1.0

1.1

211.48

228.00

mg/l

0.28

Episodal and paroxysmal disorders

955

1880

2.60

135.65

1.1

237.18

267.72

mg/l

2.61

839

1653

Migraine

563

1454

3.18

130.51

1.1

215.27

238.29

mg/l

1.62

504

1280

Other disorders of optic [2nd] nerve and visual pathways

150

157

10.08

129.40

1.1

1.0

304.12

244.64

mg/l

0.39

127

137

Dizziness and giddiness

629

1713

2.94

127.09

1.1

246.22

271.41

mg/l

2.32

555

1503

Medical observation and evaluation for suspected diseases and conditions

573

875

3.38

125.59

1.1

250.52

261.39

mg/l

0.48

533

751

L04AA Selective immunosuppressants

314

718

4.48

125.46

1.1

232.08

260.34

mg/l

1.30

260

634

Other soft tissue disorders, not elsewhere classified

860

1972

2.58

125.15

1.1

251.37

264.80

mg/l

0.49

771

1716

Cerebral cysts

144

157

9.69

120.54

1.2

1.0

288.97

256.72

mg/l

0.18

127

132

Dorsalgia

864

1837

2.54

118.79

1.1

251.85

262.99

mg/l

0.51

767

1600

Epilepsy

315

771

4.13

114.18

1.1

298.20

263.43

mg/l

0.72

287

687

Diseases of the eye and adnexa

747

1392

2.71

113.72

1.1

235.52

263.21

mg/l

2.58

662

1216

Nerve, nerve root and plexus disorders

878

2241

2.42

113.68

1.1

275.41

265.27

mg/l

0.42

764

1972

Systemic atrophies primarily affecting the central nervous system

106

14.11

113.50

1.1

277.20

286.91

mg/l

0.13

Other headache syndromes

416

1254

3.36

111.33

1.1

256.92

245.17

mg/l

0.44

358

1103

Other dorsopathies, not elsewhere classified

857

1846

2.45

108.72

1.1

246.31

264.30

mg/l

1.01

771

1608

Papilloedema, unspecified

16.92

108.27

1.2

1.0

350.95

231.46

mg/l

0.49

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

291

285

5.16

104.94

1.1

258.02

281.06

mg/l

0.63

252

258

Pain in joint

486

1001

3.12

102.38

1.1

241.14

272.25

mg/l

1.99

434

870

Care involving use of rehabilitation procedures

559

1907

2.72

101.82

1.1

254.89

264.16

mg/l

0.38

473

1695

Other special examinations and investigations of persons without complaint or reported diagnosis

528

875

3.08

100.42

1.1

243.47

261.39

mg/l

1.01

460

751

Second line medication for Crohn's disease

537

1987

2.73

100.19

1.1

241.84

260.59

mg/l

1.46

464

1755

Pain in limb

699

1895

2.49

98.52

1.1

247.84

259.93

mg/l

0.58

615

1648

Condition for Implicit Sepsis (Organ dysfunction codes)

687

1963

2.49

98.37

1.1

269.37

269.02

mg/l

0.01

604

1726

Condition for Implicit Sepsis (Organ dysfunction codes)

738

2125

2.41

98.29

1.1

274.63

263.61

mg/l

0.33

647

1869

Cerebral palsy and other paralytic syndromes

177

306

5.96

97.89

1.2

1.1

341.15

277.75

mg/l

0.63

163

264

ILD medications: prednisolone, methylprednisolone, prednisone

844

2048

2.32

97.60

1.1

252.03

276.18

mg/l

1.59

744

1799

Low back pain

628

1761

2.58

97.25

1.1

253.13

257.92

mg/l

0.18

556

1531

Implicit Sepsis

649

1888

2.53

97.15

1.1

268.87

268.84

mg/l

0.00

570

1660

L04AX Other immunosuppressants

518

1931

2.71

95.29

1.1

241.34

262.12

mg/l

1.66

446

1709

Abnormal involuntary movements

164

271

6.20

94.85

1.1

263.27

268.02

mg/l

0.08

147

235

Small fibre neuropathy

16.08

93.93

1.1

310.58

251.77

mg/l

1.31

Pain, not elsewhere classified

271

691

3.98

93.44

1.1

299.14

255.88

mg/l

0.67

233

616

Infections, IBD-co-morbidities

100

15.35

92.52

1.1

1.0

418.55

216.23

mg/l

1.42

Dorsopathies

835

1862

2.29

91.57

1.1

246.08

263.87

mg/l

0.99

743

1622

Cerebrovascular diseases (FINNGEN)

330

649

3.65

90.64

1.1

288.09

266.33

mg/l

0.61

276

573

General examination and investigation of persons without complaint and reported diagnosis

494

875

2.97

89.64

1.1

281.42

261.39

mg/l

0.50

447

751

Anxiety disorders, excluding more controls

680

1846

2.41

89.47

1.1

237.29

276.62

mg/l

3.57

587

1628

Mood disorders, excluding more controls

727

1912

2.28

82.85

1.1

248.06

280.32

mg/l

2.27

631

1688

Disorders of ocular muscles, binocular movement, accommodation and refraction

465

1761

2.65

81.53

1.1

253.11

244.60

mg/l

0.14

393

1565

Cerebrovascular diseases

491

1308

2.66

80.29

1.1

301.28

300.12

mg/l

0.02

423

1150

Lower back pain or/and sciatica

822

2556

2.11

79.46

1.1

254.74

264.30

mg/l

0.52

728

2230

Migraine with aura

281

824

3.46

79.03

1.1

205.39

226.78

mg/l

1.47

250

728

Convulsions, not elsewhere classified

235

602

3.91

78.90

1.1

234.89

269.91

mg/l

1.92

205

537

Anxiety disorders

750

2437

2.16

77.70

1.1

233.55

271.55

mg/l

3.73

649

2152

Implicit Sepsis

552

1717

2.44

77.43

1.1

272.93

273.62

mg/l

0.01

489

1505

Mood disorders

811

2513

2.10

77.09

1.1

241.15

275.28

mg/l

2.83

706

2217

Mood [affective] disorders

809

2514

2.10

76.69

1.1

241.09

275.28

mg/l

2.83

705

2217

Neurotic, stress-related and somatoform disorders

743

2432

2.15

76.42

1.1

233.26

270.49

mg/l

3.59

644

2147

Depression

770

2480

2.12

75.50

1.1

241.09

274.11

mg/l

2.56

669

2186

Paralytic strabismus

104

138

7.78

74.04

1.1

361.93

288.99

mg/l

0.30

117

Any reimbursement code in KELA

559

1127

2.51

73.63

1.1

241.35

245.08

mg/l

0.14

487

1001

Bell's palsy

147

282

5.33

72.66

1.1

348.88

264.57

mg/l

1.33

125

246

Other antidepressants

763

1833

2.14

71.89

1.1

257.23

279.35

mg/l

1.13

663

1630

Disorders of thyroid, IBD co-morbidities

10.06

71.61

1.1

237.54

194.75

mg/l

1.30

Opioids

782

1944

2.10

70.35

1.1

242.74

252.45

mg/l

0.57

681

1703

Myalgia

241

691

3.54

70.24

1.1

231.74

239.31

mg/l

0.32

220

589

First line medication for Crohn's disease

851

2296

2.01

69.28

1.1

268.73

254.64

mg/l

0.46

756

2012

Soft tissue disorders

792

1997

2.05

67.00

1.1

240.54

265.53

mg/l

1.99

714

1738

Pain (limb, back, neck, head abdominally)

507

1028

2.48

65.93

1.1

257.87

272.86

mg/l

0.67

448

895

Focal epilepsy, strict definition

206

562

3.72

64.75

1.1

264.49

264.15

mg/l

0.01

191

490

Focal epilepsy

219

626

3.55

64.16

1.1

264.04

259.25

mg/l

0.13

200

549

Other intervertebral disc disorders

579

1560

2.25

63.96

1.1

273.51

265.78

mg/l

0.24

522

1358

Examination and observation for other reasons

402

870

2.69

63.85

1.1

235.19

261.59

mg/l

1.89

376

747

Fever of other and unknown origin

381

1313

2.60

63.51

1.1

274.64

268.04

mg/l

0.18

340

1163

STROKE

419

1120

2.56

63.40

1.1

280.99

283.94

mg/l

0.09

358

981

Focal epilepsy, mode (most common among epilepsy diagnosis)

198

535

3.76

63.14

1.2

1.1

266.33

261.92

mg/l

0.11

181

467

Recurrent or chronic depression

352

899

2.78

62.69

1.1

257.45

267.13

mg/l

0.22

310

802

Persons encountering health services for specific procedures and health care

812

2508

1.95

62.27

1.1

276.62

257.75

mg/l

0.66

694

2221

Speech disturbances, not elsewhere classified

108

180

6.15

62.08

1.1

1.0

287.00

295.02

mg/l

0.11

150

Migraine without aura

232

707

3.33

61.56

1.1

222.68

224.37

mg/l

0.03

208

619

Oral corticosteroids

782

2371

1.97

61.21

1.1

254.23

271.26

mg/l

0.95

677

2083

Systemic connective tissue disorders

278

949

2.96

60.67

1.1

250.18

257.02

mg/l

0.24

237

839

Other and unspecified visual disturbances

123

237

5.31

60.59

1.1

206.87

257.78

mg/l

2.60

110

197

Spirochaetal infections, other/unspecified

263

874

3.05

60.27

1.1

330.38

255.76

mg/l

4.15

250

753

Anxiety (asthma-related co-morbidities)

538

1904

2.20

60.08

1.1

220.95

257.27

mg/l

3.05

472

1675

Neuromuscular dysfunction of bladder

115

212

5.56

59.50

1.1

340.19

284.33

mg/l

0.36

178

Lyme disease

260

866

3.04

59.35

1.1

331.48

256.31

mg/l

4.13

247

747

Other spirochaetal diseases

264

887

3.01

59.34

1.1

330.14

255.47

mg/l

4.19

251

766

Other spirochaetal diseases

262

879

3.02

59.05

1.1

331.43

254.92

mg/l

4.32

249

759

Sciatica+with lumbago

371

1361

2.53

58.72

1.1

264.99

269.31

mg/l

0.12

327

1186

Persons encountering health services for examination and investigation

437

875

2.52

58.48

1.1

255.73

261.39

mg/l

0.20

388

751

Inflammatory bowel disease treatment related agents

839

2488

1.90

58.19

1.1

250.78

267.24

mg/l

1.06

732

2190

Any mental disorder

758

1929

1.98

57.65

1.1

244.99

279.98

mg/l

3.27

669

1701

Alzheimer disease, excluding more controls

11.58

57.30

1.0

278.68

340.86

mg/l

0.41

Certain disorders involving the immune mechanism

190

536

3.60

56.93

1.2

1.1

293.89

269.77

mg/l

0.53

170

470

Extrapyramidal and movement disorders

264

912

2.92

56.40

1.1

253.63

278.82

mg/l

1.20

228

802

Sarcoidosis

145

340

4.35

56.34

1.1

311.40

278.64

mg/l

0.57

126

289

Strabismus

266

926

2.90

55.88

1.1

276.79

248.53

mg/l

0.31

223

820

Ischaemic Stroke, excluding all haemorrhages

320

886

2.71

55.33

1.1

278.48

313.93

mg/l

1.57

272

773

Stroke, excluding SAH

344

975

2.59

54.46

1.1

286.18

307.57

mg/l

0.78

291

852

Depression or dysthymia

452

1067

2.35

54.10

1.1

266.99

291.75

mg/l

0.88

390

955

Implicit viral Sepsis

216

682

3.20

53.98

1.2

1.1

285.74

276.24

mg/l

0.18

192

597

All anxiety disorders

545

2076

2.09

53.61

1.1

219.90

251.57

mg/l

2.61

479

1837

Use of glatiramer acetate

12.17

53.31

1.0

1.1

209.47

228.25

mg/l

0.37

Tramadol

555

1624

2.11

53.09

1.1

276.25

259.04

mg/l

0.78

485

1424

Lumbar disc prolapse

432

1471

2.27

51.80

1.1

266.89

270.51

mg/l

0.09

386

1280

Spondylopathies

482

1318

2.20

50.53

1.1

298.02

277.81

mg/l

0.66

418

1150

Other disorders of lacrimal gland

277

1042

2.69

50.47

1.1

254.61

254.59

mg/l

0.00

244

901

Codeine

680

1911

1.94

50.46

1.1

248.32

253.36

mg/l

0.23

593

1673

Stroke, including SAH

355

1055

2.46

50.29

1.1

286.66

306.41

mg/l

0.72

302

925

Other disorders of eye and adnexa

160

443

3.68

49.43

1.1

245.65

246.22

mg/l

0.01

151

382

Depression medications

289

511

2.87

49.16

1.1

1.0

230.14

224.02

mg/l

0.21

246

454

Symptoms and signs involving speech and voice

251

910

2.79

49.14

1.1

251.41

260.53

mg/l

0.31

228

793

Certain infectious and parasitic diseases

700

1838

1.92

48.88

1.1

263.72

241.55

mg/l

1.34

628

1598

Parkinson's disease, excluding more controls

10.68

48.22

1.2

1.1

269.67

280.55

mg/l

0.12

Dysphagia

180

547

3.32

48.00

1.1

361.46

276.15

mg/l

1.17

161

477

Diagnoses used for exclusion with ILD

193

614

3.18

47.75

1.1

337.95

280.25

mg/l

0.70

169

538

Other/unspecified dorsalgia

265

1011

2.62

46.03

1.1

235.00

251.13

mg/l

0.91

234

877

Diseases of the musculoskeletal system and connective tissue

424

942

2.27

45.73

1.1

232.88

258.06

mg/l

1.00

375

817

Parkinson's disease, strict definition, excluding more controls

10.90

45.51

1.2

1.0

276.30

284.82

mg/l

0.09

Other anxiety disorders

422

1722

2.14

45.13

1.1

225.24

246.19

mg/l

1.06

370

1524

Psychiatric diseases

655

1729

1.91

45.08

1.1

248.72

279.55

mg/l

2.39

571

1531

Migraine with aura and triptan purchases

189

619

3.10

44.70

1.1

203.71

221.09

mg/l

0.93

172

540

Disorders of lacrimal system

306

1277

2.41

44.60

1.1

257.58

257.31

mg/l

0.01

272

1112

Ocular pain

109

247

4.52

44.43

1.1

241.97

246.71

mg/l

0.07

102

209

Any gastric operation

593

1533

1.95

43.60

1.1

243.13

247.09

mg/l

0.14

516

1354

GASTRO-related operations

593

1533

1.95

43.60

1.1

243.13

247.09

mg/l

0.14

516

1354

Symptoms and signs involving the circulatory and respiratory systems

736

2045

1.81

43.38

1.1

244.44

266.84

mg/l

0.79

649

1805

Other general symptoms and signs

105

6.68

42.89

1.1

1.0

205.84

221.36

mg/l

0.44

Syncope and collapse

260

866

2.59

42.78

1.1

244.10

279.50

mg/l

2.22

232

772

Implicit viral Sepsis

151

447

3.42

42.07

1.2

1.1

306.11

282.80

mg/l

0.35

135

387

Viral Sepsis

151

448

3.41

41.93

1.2

1.1

306.11

283.65

mg/l

0.34

135

388

Abnormalities of breathing

642

2031

1.84

41.65

1.1

236.37

266.65

mg/l

3.21

559

1791

Other specific joint derangements/joint disorders

576

1974

1.90

41.60

1.1

238.31

256.76

mg/l

1.07

512

1726

Parasetamol

562

1469

1.95

41.39

1.1

247.50

265.72

mg/l

0.84

495

1294

Spondylosis

305

1055

2.37

41.27

1.1

288.02

290.41

mg/l

0.05

259

910

Cardiovascular diseases

555

1544

1.94

41.21

1.1

226.88

235.55

mg/l

0.37

502

1349

Other extrapyramidal and movement disorders in other diseases

175

576

3.07

40.96

1.1

242.20

271.87

mg/l

1.07

152

502

Viral infections of the central nervous system

102

235

4.45

40.75

1.3

1.1

315.50

268.47

mg/l

1.03

201

Codeine or tramadol medication

775

2455

1.73

40.47

1.1

248.04

266.47

mg/l

1.35

674

2149

Hemiplegia

110

6.35

40.39

1.2

1.1

237.60

247.51

mg/l

0.22

Other systemic involvement of connective tissue (FG)

186

642

2.89

38.96

1.1

232.83

260.03

mg/l

1.36

159

556

Fibromyalgia

103

249

4.22

38.61

1.1

200.94

226.75

mg/l

1.51

213

Migraine without aura and triptan purchases

186

663

2.85

37.87

1.1

228.16

221.94

mg/l

0.12

166

584

Somatoform disorder

157

511

3.12

37.58

1.1

211.31

250.05

mg/l

3.14

128

448

Non-invasive ventilation

188

595

2.85

37.55

1.1

288.22

254.84

mg/l

0.33

154

524

Visual field defects

170

4.91

37.24

1.1

261.63

272.65

mg/l

0.19

146

ILD differential diagnosis

538

1422

1.90

37.08

1.1

249.15

261.42

mg/l

0.66

474

1240

COPD differential diagnosis

538

1423

1.90

37.00

1.1

249.15

261.54

mg/l

0.67

474

1241

Radiculopathy

111

292

3.84

36.95

1.1

282.25

270.52

mg/l

0.21

250

Viral infections of the central nervous system

220

4.38

36.84

1.3

1.1

317.93

264.07

mg/l

1.16

187

Cervicobrachial syndrome

166

564

2.97

36.79

1.1

237.98

246.48

mg/l

0.24

155

487

Pain in throat and chest

582

1926

1.82

36.74

1.1

266.21

272.05

mg/l

0.11

506

1697

Cardiovascular diseases (excluding rheumatic etc)

553

1726

1.85

36.33

1.1

237.92

239.51

mg/l

0.05

495

1515

Cervicalgia

150

485

3.12

36.25

1.1

294.63

247.88

mg/l

1.00

130

418

Excluding asthma or asthma-COPD overlap

535

1426

1.89

35.99

1.1

249.46

261.29

mg/l

0.63

471

1243

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

15.44

35.98

1.1

1.0

285.82

219.31

mg/l

0.87

Hypothyroidism, strict autoimmune

409

1341

2.01

35.49

1.1

240.16

264.22

mg/l

1.24

359

1176

Other systemic involvement of connective tissue

192

722

2.68

35.20

1.1

232.58

252.35

mg/l

1.00

165

640

Diseases of the myoneural junction and muscle

105

278

3.83

34.73

1.1

364.57

299.39

mg/l

0.70

235

Oedema, not elsewhere classified

180

649

2.75

34.72

1.1

251.02

276.05

mg/l

0.73

153

579

Chorioretinal inflammation

8.00

34.22

1.2

1.1

238.34

232.06

mg/l

0.12

Disorders of vestibular function (Vertigo)

282

1259

2.22

34.00

1.1

246.75

272.83

mg/l

1.80

250

1104

SLE (Finngen)

8.54

33.98

1.1

302.69

242.77

mg/l

0.63

Other pulmonary diagnosis

526

1426

1.86

33.66

1.1

249.21

261.29

mg/l

0.66

462

1243

Cervical disc disorders

209

840

2.50

33.41

1.1

259.63

280.44

mg/l

0.56

186

727

Symptoms and signs involving the urinary system

453

1842

1.88

33.33

1.1

313.11

269.13

mg/l

1.23

399

1629

Status epilepticus

7.88

33.27

1.2

1.0

283.72

268.61

mg/l

0.13

Other diseases of spinal cord

7.81

32.87

1.2

1.1

265.02

255.74

mg/l

0.12

Asthma, excluding more controls

494

1382

1.87

32.84

1.1

236.53

261.29

mg/l

1.77

432

1203

Organic, including symptomatic, mental disorders

239

708

2.42

32.82

1.1

269.05

326.63

mg/l

3.97

202

620

Symptoms and signs involving the digestive system and abdomen

640

1859

1.73

32.71

1.1

274.29

268.54

mg/l

0.12

568

1638

Asthma

499

1411

1.86

32.67

1.1

236.68

261.11

mg/l

1.77

435

1229

Provisional assignment of new diseases of uncertain etiology

368

1882

1.96

32.23

1.1

281.02

250.95

mg/l

0.61

327

1647

Codes for special purposes

368

1887

1.96

31.99

1.1

281.02

251.07

mg/l

0.61

327

1652

Hard cardiovascular diseases

494

1615

1.83

31.75

1.1

261.16

292.57

mg/l

2.06

421

1429

Polyuria

148

513

2.91

31.72

1.1

256.50

296.59

mg/l

1.65

128

447

Anaemias

186

450

2.72

31.60

1.1

1.0

255.41

223.69

mg/l

0.67

150

398

Antihypertensive medication - note that there are other indications

524

1551

1.80

30.93

1.1

224.12

246.77

mg/l

1.20

459

1364

Sequelae of cerebrovascular disease

173

561

2.68

30.71

1.1

305.33

305.97

mg/l

0.01

153

497

Other and unspecified nerve root and plexus disorders, also in other diseases

152

545

2.82

30.65

1.1

286.48

263.39

mg/l

0.32

132

482

Asthma (mode)

484

1422

1.83

30.27

1.1

234.14

261.42

mg/l

2.08

420

1240

Other reaction to severe stress, and adjustment disorders

305

1497

2.05

30.26

1.1

236.51

237.79

mg/l

0.04

261

1319

Triptan medication for migraine, single purchase ok

564

2230

1.72

30.22

1.1

224.99

260.01

mg/l

3.13

498

1959

Migraine, single triptan purchase ok & required. ICD-code if available is included

564

2230

1.72

30.22

1.1

224.99

260.01

mg/l

3.13

498

1959

Factors influencing health status and contact with health services

176

311

2.85

30.06

1.1

287.05

266.75

mg/l

0.49

154

267

Follow-up examination after treatment for conditions other than malignant neoplasms

251

731

2.28

29.95

1.1

262.56

256.26

mg/l

0.07

222

629

Symptoms and signs concerning food and fluid intake

186

4.24

29.71

1.1

1.0

269.77

279.69

mg/l

0.12

164

Enlarged lymph nodes

114

353

3.26

29.71

1.2

1.1

265.98

272.30

mg/l

0.11

314

Other disorders of binocular movement

7.12

29.50

1.1

218.73

240.48

mg/l

0.27

Other disorders of urethra and urinary system

444

1763

1.83

29.48

1.1

271.89

254.78

mg/l

0.33

385

1547

Sixth [abducent] nerve palsy

7.03

29.41

1.1

209.62

255.61

mg/l

1.27

Implicit bacterial Sepsis

223

834

2.32

29.37

1.1

340.03

296.80

mg/l

0.52

187

733

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

223

980

2.28

29.01

1.1

227.85

240.20

mg/l

0.53

199

870

Hypothyroidism (congenital or acquired)

212

486

2.48

28.93

1.1

1.0

231.08

220.00

mg/l

0.34

184

431

ILD medications: azathioprine

124

413

3.04

28.63

1.2

1.1

289.94

256.79

mg/l

0.84

106

371

Diseases of inner ear

306

1482

2.01

28.50

1.1

244.98

277.96

mg/l

2.88

272

1305

Disorders of eyelid, lacrimal system and orbit

514

2277

1.72

28.24

1.1

260.21

271.00

mg/l

0.50

458

1997

Disorders of refraction and accommodation

219

967

2.28

28.23

1.1

217.29

241.82

mg/l

1.38

184

858

Hypothyroidism, levothyroxine purchases

209

484

2.46

28.01

1.1

1.0

224.68

219.75

mg/l

0.13

180

429

Hypothyroidism and >3 levothyroxin purchases

209

484

2.46

28.01

1.1

1.0

224.68

219.75

mg/l

0.13

180

429

Trigeminal neuralgia

122

5.02

27.96

1.1

250.91

252.19

mg/l

0.01

107

Primary_lymphoid and hematopoietic malignant neoplasms

142

516

2.77

27.93

1.2

1.1

396.29

289.34

mg/l

1.79

125

452

Nausea and vomiting

178

707

2.48

27.93

1.1

318.70

246.26

mg/l

0.63

155

618

Diseases of the ear and mastoid process

764

2439

1.58

27.52

1.1

245.51

268.91

mg/l

1.84

679

2132

Other necrotizing vasculopathies (FG)

102

5.39

27.33

1.1

249.02

308.68

mg/l

1.15

Other joint disorders

625

2004

1.65

27.33

1.1

233.67

258.21

mg/l

2.06

561

1755

Liquid cancers, helper endpoint

211

809

2.29

26.98

1.2

1.1

370.15

276.41

mg/l

2.55

185

719

Spinal stenosis

220

741

2.26

26.69

1.1

358.41

300.13

mg/l

1.56

192

637

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

104

5.26

26.65

1.3

1.0

291.67

270.09

mg/l

0.33

Malignant neoplasm of brain, including Hilmo

112

5.11

26.63

1.1

591.17

262.83

mg/l

1.06

100

Asthma (only as main-diagnosis)

436

1411

1.80

26.25

1.1

223.14

261.11

mg/l

4.44

381

1229

Asthma (only as main-diagnosis), excluding more controls

433

1382

1.80

26.14

1.1

223.16

261.29

mg/l

4.38

379

1203

Meningitis

134

4.66

25.99

1.1

485.72

275.72

mg/l

2.25

112

Selective serotonin reuptake inhibitors

583

1840

1.66

25.99

1.1

251.23

279.24

mg/l

1.80

514

1637

Abdominal and pelvic pain

606

1859

1.64

25.76

1.1

266.00

268.54

mg/l

0.06

546

1638

Implicit bacterial Sepsis

196

756

2.31

25.75

1.1

352.98

300.06

mg/l

0.59

166

659

Special screening examination for infectious and parasitic diseases

190

594

2.37

25.40

1.1

252.98

238.78

mg/l

0.48

178

516

Other strabismus

180

766

2.36

25.38

1.1

224.74

243.99

mg/l

0.74

155

680

Benzodiazepine use

627

2715

1.60

25.33

1.1

250.71

268.27

mg/l

0.79

539

2391

Oxycodone

192

756

2.31

25.33

1.1

399.34

289.74

mg/l

1.67

166

661

Other disorders of nervous system

137

4.53

25.26

1.3

1.0

379.65

285.92

mg/l

0.79

114

Persons encountering health services in other circumstances, wide

711

2348

1.56

24.88

1.1

275.52

266.89

mg/l

0.24

628

2058

Covid-19 confirmed case

225

1062

2.13

24.85

1.1

317.55

258.40

mg/l

0.82

193

937

Other diseases of urinary system

618

2166

1.61

24.85

1.1

275.92

258.25

mg/l

0.50

539

1918

Pain in thoracic spine

110

372

2.99

24.78

1.1

210.59

247.27

mg/l

2.03

319

Sleep disorders (combined)

700

2358

1.56

24.56

1.1

244.80

267.01

mg/l

1.64

605

2084

Dermatitis

373

2092

1.78

24.43

1.1

277.66

266.36

mg/l

0.24

331

1839

Malignant neoplasm of brain

5.87

24.24

1.0

1.1

632.29

268.62

mg/l

0.91

Other and unspecified dermatitis

323

1747

1.86

24.16

1.1

280.20

258.38

mg/l

0.48

285

1541

Any dementia, excluding more controls

134

336

2.76

23.93

1.1

265.56

328.41

mg/l

2.67

113

297

Other mental disorders due to brain damage and dysfunction and to physical disease

187

3.84

23.76

1.1

1.0

272.25

319.40

mg/l

1.44

162

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

590

2566

1.59

23.64

1.1

288.58

261.28

mg/l

0.89

501

2266

Coxibs

184

403

2.42

23.46

1.1

237.45

273.49

mg/l

1.49

157

348

Bacterial infection, other or unspecified

278

1245

1.95

23.41

1.1

341.51

275.05

mg/l

1.29

235

1102

Dyspnoea

524

2386

1.63

23.39

1.1

240.65

273.25

mg/l

3.36

463

2086

Asthma, unspecified (mode), excluding more controls

311

1236

1.89

23.37

1.1

237.48

265.89

mg/l

1.58

264

1080

Non-Hodgkin lymphoma, all, including Hilmo

251

3.38

23.29

1.2

1.1

490.38

284.32

mg/l

2.29

222

Certain infectious and parasitic diseases

460

1343

1.72

23.29

1.1

266.72

244.84

mg/l

0.94

405

1167

Bacterial Sepsis

221

901

2.11

23.07

1.1

350.39

293.69

mg/l

0.76

187

791

Other sleep disorders

248

3.39

23.04

1.2

1.0

247.85

279.77

mg/l

0.70

215

Asthma, unspecified (mode)

312

1256

1.88

23.03

1.1

237.47

265.32

mg/l

1.55

265

1098

Abnormal findings on diagnostic imaging of lung

215

983

2.11

22.94

1.1

306.91

298.23

mg/l

0.18

192

858

Other necrotizing vasculopathies

136

4.33

22.76

1.1

257.39

290.98

mg/l

0.62

122

Lesion of lateral popliteal nerve

108

4.82

22.73

1.2

1.1

302.91

282.79

mg/l

0.10

Degenerative diseases of the nervous system

126

339

2.74

22.72

1.1

304.68

326.32

mg/l

0.21

107

300

Brachial plexus disorders

286

3.19

22.66

1.1

309.97

247.37

mg/l

0.58

257

Heterophoria

248

3.36

22.39

1.1

216.83

237.66

mg/l

0.46

212

Dissociative [conversion] disorders

130

4.42

22.35

1.1

188.46

220.10

mg/l

1.30

110

Triptan medication for migraine, min. 3 purchases

439

2005

1.68

22.19

1.1

217.99

234.05

mg/l

0.84

390

1753

Persons encountering health services for other counselling and medical advice, not elsewhere classified

664

2348

1.54

22.18

1.1

272.45

266.89

mg/l

0.14

598

2058

Azathioprine

124

476

2.63

22.08

1.2

1.1

289.94

260.65

mg/l

0.70

106

423

Other symptoms and signs involving the urinary system

233

3.39

21.69

1.2

1.1

342.71

302.11

mg/l

0.25

195

Cervicocranial syndrome

238

3.36

21.67

1.1

273.04

243.37

mg/l

0.38

205

Dementia, including avohilmo

172

513

2.31

21.58

1.1

266.98

322.29

mg/l

3.18

146

448

Systemic lupus erythematosus

5.25

21.55

1.1

302.69

233.01

mg/l

0.97

Finngen Rheumatological endpoints

629

2324

1.54

21.41

1.1

239.84

262.33

mg/l

1.80

556

2035

Visual impairment including blindness (binocular or monocular)

130

4.29

21.37

1.2

1.0

275.53

255.69

mg/l

0.30

110

Bacterial infection, other or unspecified

297

1366

1.85

21.26

1.1

345.44

270.35

mg/l

1.54

252

1215

Cough

239

1157

1.96

21.04

1.1

225.31

271.22

mg/l

3.62

210

1021

Abnormalities of heart beat

216

1050

2.03

20.93

1.1

233.00

261.09

mg/l

1.63

185

924

Acute upper respiratory infections

615

2471

1.54

20.90

1.1

244.63

269.87

mg/l

1.86

530

2179

Irritable bowel syndrome

199

963

2.08

20.72

1.1

260.67

244.63

mg/l

0.38

176

832

Shoulder lesions

403

1440

1.70

20.53

1.1

273.39

281.07

mg/l

0.21

364

1256

Dementia

156

459

2.35

20.25

1.1

258.26

322.10

mg/l

4.06

132

405

Malignant neoplasm of eye, brain and central nervous system

4.83

20.16

1.0

1.1

626.59

268.01

mg/l

0.93

Transient ischemic attack

219

885

2.01

20.09

1.1

290.49

302.09

mg/l

0.31

191

772

Arthropathies

609

2009

1.54

20.05

1.1

237.89

257.97

mg/l

1.36

539

1759

Any dementia

136

383

2.48

19.86

1.1

264.69

328.37

mg/l

2.80

114

336

Dermatitis and eczema

666

2771

1.49

19.84

1.1

263.47

266.10

mg/l

0.07

582

2436

Intracranial injury

345

1910

1.72

19.66

1.1

257.89

267.89

mg/l

0.16

292

1692

Other meningitis

7.37

19.63

1.1

344.68

214.75

mg/l

1.60

Personality disorders, excluding more controls

188

910

2.08

19.58

1.1

198.36

244.40

mg/l

6.61

163

807

Sleep apnoea

523

2170

1.56

19.45

1.1

281.40

278.79

mg/l

0.08

450

1917

117

468

2.53

19.22

1.1

236.91

232.56

mg/l

0.09

408

Lesion of ulnar nerve

335

2.80

18.80

1.1

281.98

280.25

mg/l

0.01

292

Other disorders of fluid, electrolyte and acid-base balance

154

665

2.22

18.79

1.1

338.08

287.20

mg/l

0.82

131

582

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

307

1722

1.74

18.51

1.1

263.34

273.11

mg/l

0.30

270

1498

Gastrointestinal diseases

420

1281

1.65

18.30

1.1

229.96

259.53

mg/l

1.77

364

1126

Other functional intestinal disorders

257

1310

1.83

18.22

1.1

297.45

260.19

mg/l

0.88

212

1147

Cystitis

495

1888

1.56

18.09

1.1

264.12

252.08

mg/l

0.27

422

1661

SLE, ICD10

4.78

18.06

1.1

289.31

229.83

mg/l

0.80

SLE, strict definition

4.78

18.06

1.1

289.31

229.83

mg/l

0.80

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.90

17.81

1.2

1.0

346.21

272.33

mg/l

1.21

Exclusions for E4_PCOS_BROAD

134

590

2.29

17.77

1.1

274.70

252.80

mg/l

0.29

108

515

Gastro-oesophageal reflux disease

378

2002

1.63

17.77

1.1

267.19

278.71

mg/l

0.29

337

1763

Acute upper respiratory infections of multiple and unspecified sites

469

2236

1.56

17.67

1.1

259.33

256.39

mg/l

0.06

408

1973

Nonorganic sleeping disorders, excluding more controls

136

606

2.26

17.55

1.1

212.31

249.26

mg/l

2.43

118

537

Retention of urine

155

589

2.17

17.48

1.1

381.53

303.20

mg/l

0.77

138

509

Diseases of oesophagus, stomach and duodenum

620

2523

1.47

17.24

1.1

255.90

266.21

mg/l

0.51

539

2216

Dentofacial anomalies [including malocclusion]

469

2446

1.55

17.20

1.1

237.86

253.36

mg/l

0.56

405

2157

Optic atrophy

7.07

17.08

1.1

246.19

197.19

mg/l

0.91

Bronchitis

631

2725

1.46

17.05

1.1

243.59

266.11

mg/l

1.76

543

2399

Hypertensive diseases (excluding secondary)

348

1209

1.68

16.86

1.1

265.87

249.64

mg/l

0.65

306

1064

Complications of medical and surgical care

405

2365

1.58

16.73

1.1

261.36

268.68

mg/l

0.14

355

2085

Other diseases of upper respiratory tract

620

2201

1.47

16.69

1.1

258.94

273.77

mg/l

0.75

553

1913

Other shoulder lesions

231

3.06

16.63

1.1

267.67

259.79

mg/l

0.08

193

Atypical facial pain

111

4.12

16.62

1.2

1.0

212.55

248.88

mg/l

1.19

100

Speech and linguistic disorders, excluding more controls

246

2.94

16.56

1.1

258.67

242.55

mg/l

0.18

209

Diarrhoea and gastroenteritis of presumed infectious origin

595

2680

1.47

16.53

1.1

247.55

264.84

mg/l

1.12

526

2347

Cluster headache, strict

4.78

16.39

1.2

1.1

245.82

254.94

mg/l

0.13

Optic atrophy

6.73

16.31

1.1

246.19

202.68

mg/l

0.78

Delirium, not induced by alcohol and other psychoactive substances

178

3.33

16.17

1.1

1.0

288.43

338.38

mg/l

0.76

153

Vocal cord dysfunction

306

2.66

16.17

1.1

274.94

262.74

mg/l

0.22

269

Implicit fungal Sepsis

132

3.76

16.02

1.2

1.0

260.33

289.79

mg/l

0.42

117

Cluster headache, wide

4.65

15.91

1.2

1.0

245.82

252.08

mg/l

0.09

Viral infections characterized by skin and mucous membrane lesions

507

2920

1.49

15.81

1.1

277.43

259.89

mg/l

0.58

451

2555

Use of pramipexole

115

500

2.32

15.77

1.1

254.74

281.08

mg/l

0.69

100

434

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.81

15.69

1.2

1.1

536.59

258.76

mg/l

1.50

Respiratory insufficiency

4.21

15.67

1.0

1.1

508.51

313.93

mg/l

0.51

Acute sinusitis

341

1959

1.62

15.62

1.1

239.18

251.18

mg/l

0.58

294

1725

Other medical care

214

1048

1.84

15.61

1.1

368.31

270.88

mg/l

1.32

181

929

Diseases of the respiratory system

377

1168

1.62

15.55

1.1

255.78

261.21

mg/l

0.17

328

1024

Functional dyspepsia

163

822

2.00

15.31

1.0

1.1

251.75

256.65

mg/l

0.10

143

727

Obesity related asthma

203

1102

1.85

15.27

1.1

240.85

264.23

mg/l

1.59

170

969

Hypo-osmolality and hyponatraemia

319

2.64

15.21

1.1

399.46

287.42

mg/l

1.09

276

Abnormal findings on diagnostic imaging of other body structures

293

2.72

15.19

1.2

1.1

269.57

270.29

mg/l

0.01

256

COPD/asthma related infections

602

2078

1.45

15.19

1.1

245.20

260.66

mg/l

0.90

525

1833

COPD/asthma/ILD related infections

602

2078

1.45

15.19

1.1

245.20

260.66

mg/l

0.90

525

1833

Sleep apnoea, including avohilmo

548

2317

1.47

15.18

1.1

275.04

274.79

mg/l

0.01

472

2050

Chronic sinusitis

252

1462

1.73

15.09

1.1

250.70

258.84

mg/l

0.25

222

1277

Other symptoms and signs involving the digestive system and abdomen

388

2.47

15.01

1.1

288.30

248.14

mg/l

0.53

339

Other diseases of intestines

646

2590

1.42

14.86

1.1

253.30

261.08

mg/l

0.28

576

2273

Rheumatism, unspecified

280

2.74

14.81

1.1

257.00

250.98

mg/l

0.06

238

Metabolic disorders

519

2153

1.47

14.66

1.1

275.39

271.35

mg/l

0.13

454

1889

639

2322

1.43

14.60

1.1

245.19

271.25

mg/l

2.00

548

2052

Other disorders of bladder

233

2.90

14.55

1.1

266.90

318.32

mg/l

1.11

197

Asthma (diagnoses ohter than nonallergic)

501

2843

1.47

14.46

1.1

232.24

268.81

mg/l

3.60

434

2500

Asthma, hospital admission 2, infections

332

2048

1.59

14.43

1.1

236.10

264.52

mg/l

1.71

283

1809

Asthma-related infections

332

2048

1.59

14.43

1.1

236.10

264.52

mg/l

1.71

283

1809

Other external causes of accidental injury

490

1643

1.50

14.35

1.1

261.59

259.47

mg/l

0.06

425

1444

Benign neoplasm of meninges

219

2.95

14.33

1.1

334.57

265.28

mg/l

0.97

190

Intestinal infectious diseases

547

2886

1.44

14.30

1.1

277.66

261.93

mg/l

0.38

477

2536

Benign paroxysmal vertigo

145

720

2.02

14.25

1.1

260.89

269.90

mg/l

0.24

129

631

Fall on same level

685

2682

1.40

14.20

1.1

258.20

260.77

mg/l

0.10

601

2357

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

253

2.80

14.20

1.1

233.26

262.46

mg/l

0.76

223

Dental pulpitis, including avohilmo

579

2634

1.43

14.14

1.1

237.44

265.79

mg/l

2.14

494

2329

Constipation

458

2129

1.49

14.09

1.1

297.45

268.73

mg/l

0.93

384

1884

Voice disturbances

149

751

2.00

14.06

1.1

229.60

259.93

mg/l

1.69

136

653

Unspecified dementia

3.87

14.04

1.0

263.31

321.55

mg/l

1.40

Viral infections characterized by skin and mucous membrane lesions

246

1449

1.70

13.99

1.1

290.74

256.94

mg/l

1.05

224

1288

Osteopathies and chondropathies

292

1673

1.63

13.93

1.1

272.67

262.60

mg/l

0.24

243

1483

Benign neoplasm: Cerebral meninges

196

3.04

13.92

1.1

319.62

257.79

mg/l

0.85

170

Restless leg syndrome

349

2.49

13.84

1.1

234.13

264.27

mg/l

0.75

304

Injuries to the head

641

2818

1.40

13.83

1.1

281.41

260.34

mg/l

0.67

556

2480

Rotator cuff syndrome

282

1222

1.66

13.83

1.0

1.1

275.97

291.29

mg/l

0.56

257

1064

Other symptoms and signs involving the circulatory and respiratory systems

171

3.20

13.83

1.1

367.84

301.95

mg/l

0.20

140

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

223

1285

1.75

13.82

1.1

227.85

232.43

mg/l

0.16

199

1134

Disorders of sclera, cornea, iris and ciliary body

312

1961

1.60

13.79

1.1

280.87

261.71

mg/l

0.59

267

1742

Enthesopathies of lower limb, excluding foot

121

572

2.13

13.59

1.1

268.03

248.62

mg/l

0.45

112

493

Intestinal infectious diseases

650

2665

1.40

13.56

1.1

277.81

264.91

mg/l

0.35

573

2336

Accidents

485

1643

1.48

13.56

1.1

260.50

259.47

mg/l

0.03

420

1444

Temporomandibular joint disorders, including avohilmo

311

1935

1.59

13.51

1.1

226.16

225.39

mg/l

0.03

269

1692

Non-follicular lymphoma

184

3.07

13.48

1.2

1.0

404.44

297.72

mg/l

1.07

155

Asthma, including avohilmo

679

2761

1.38

13.41

1.1

234.35

271.59

mg/l

4.32

587

2436

Chronic diseases of tonsils and adenoids

479

2067

1.47

13.41

1.1

245.39

266.60

mg/l

1.12

429

1798

Disorders of other endocrine glands

257

1525

1.66

13.39

1.1

255.79

246.25

mg/l

0.18

214

1351

Hypertension, essential

450

1713

1.49

13.29

1.1

273.32

269.87

mg/l

0.11

393

1510

Neoplasms

523

1917

1.45

13.23

1.1

266.44

236.63

mg/l

0.81

462

1677

Falls/tendency to fall

651

2341

1.40

13.21

1.1

255.66

258.90

mg/l

0.11

572

2058

Metatarsalgia

220

2.84

13.03

1.0

1.1

261.98

257.81

mg/l

0.06

185

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

496

2076

1.45

12.92

1.1

296.53

260.82

mg/l

1.00

434

1831

496

2076

1.45

12.92

1.1

296.53

260.82

mg/l

1.00

434

1831

Sleep disorders

527

2679

1.43

12.90

1.1

237.12

265.35

mg/l

1.42

459

2361

Endocrine, nutritional and metabolic diseases

521

1831

1.44

12.84

1.1

254.30

256.23

mg/l

0.05

451

1624

Viral meningitis

110

3.71

12.80

1.2

1.0

343.60

244.29

mg/l

1.40

Genitourinary diseases

357

1152

1.56

12.61

1.1

261.21

271.00

mg/l

0.33

319

1015

Adrenocortical insufficiency

4.12

12.61

1.2

1.1

406.33

237.54

mg/l

0.66

Exposure to unspecified factor

567

2923

1.40

12.51

1.1

282.41

260.78

mg/l

0.59

484

2578

Disorders of muscles

231

2.75

12.47

1.1

404.22

268.43

mg/l

0.57

194

Undefined dementia

110

3.54

12.46

1.0

1.1

263.31

288.33

mg/l

0.55

Other respiratory disorders and diseases

404

2.29

12.43

1.0

1.1

386.06

300.93

mg/l

0.46

352

Other diseases of the respiratory system

404

2.29

12.43

1.0

1.1

386.06

300.93

mg/l

0.46

352

Persons encountering health services in other circumstances

236

1417

1.66

12.34

1.1

307.06

248.00

mg/l

0.84

196

1242

Dystonia

132

3.38

12.34

1.1

221.26

249.82

mg/l

0.80

112

Behavioural syndromes associated with physiological disturbances and physical factors

539

2721

1.41

12.33

1.1

240.79

265.41

mg/l

1.14

469

2396

Chronic lower respiratory diseases

699

2743

1.36

12.31

1.1

252.25

267.35

mg/l

0.53

609

2415

Other enthesopathy of foot (+metatarsalgia)

239

2.70

12.24

1.0

1.1

262.29

255.07

mg/l

0.11

201

268

1662

1.61

12.17

1.1

233.98

248.21

mg/l

0.55

228

1463

Injuries to the neck

158

855

1.86

12.15

1.1

278.18

250.84

mg/l

0.24

143

753

Use of hypnotics and sedatives

592

2452

1.39

12.07

1.1

257.65

270.48

mg/l

0.69

522

2154

Panic disorder

118

580

2.05

12.05

1.1

201.33

237.96

mg/l

2.31

107

513

Unknown and unspecified causes of morbidity

139

3.27

12.03

1.2

1.1

235.49

283.45

mg/l

1.08

125

Osteoporosis

106

465

2.14

12.03

1.1

348.13

273.13

mg/l

1.03

411

Chronic laryngitis and laryngotracheitis

336

2.40

12.00

1.1

299.53

271.84

mg/l

0.32

290

Dislocation, sprain and strain of joints and ligaments at neck level

120

595

2.03

11.97

1.1

223.62

244.09

mg/l

0.67

108

524

Hypermetropia

203

2.84

11.93

1.1

205.30

253.82

mg/l

1.26

174

N06DA Anticholinesterases

100

358

2.21

11.90

1.1

265.42

329.70

mg/l

2.85

312

Use of anticholinesterases

100

358

2.21

11.90

1.1

265.42

329.70

mg/l

2.85

312

Non-selective monoamine reuptake inhibitors

167

892

1.81

11.79

1.1

257.78

273.63

mg/l

0.33

141

801

Dental caries

148

760

1.88

11.77

1.1

266.03

300.71

mg/l

0.95

130

665

Zoster [herpes zoster]

416

2.23

11.63

1.3

1.1

339.71

271.78

mg/l

0.85

364

Other heart diseases

296

1233

1.57

11.55

1.1

233.37

250.17

mg/l

0.92

264

1083

Transport accidents

276

1507

1.58

11.54

1.1

260.58

256.16

mg/l

0.05

246

1321

Non-Hodgkin lymphoma, all

4.32

11.50

1.2

1.1

661.00

254.71

mg/l

1.65

Hydrocephalus

138

3.22

11.49

1.1

1.0

459.38

271.32

mg/l

0.92

114

Ptosis of eyelid

219

2.72

11.44

1.3

1.0

251.11

279.80

mg/l

0.78

184

Cardiac arrhythmias

370

1614

1.49

11.43

1.1

234.60

242.46

mg/l

0.37

315

1434

Exposure to other specified factors

438

2818

1.43

11.42

1.1

270.74

261.39

mg/l

0.19

387

2467

Influenza and pneumonia

603

2810

1.37

11.41

1.1

286.66

256.31

mg/l

1.05

531

2465

Other diseases of blood and blood-forming organs, wide

118

592

2.00

11.39

1.1

342.65

271.58

mg/l

0.50

518

Cluster headache, strict, including avohilmo

155

3.08

11.34

1.3

1.1

245.49

256.26

mg/l

0.20

129

Injuries to the wrist and hand

569

2873

1.37

11.32

1.1

274.22

261.16

mg/l

0.34

497

2524

Hypermobility syndrome

193

2.84

11.30

1.0

1.1

202.21

210.43

mg/l

0.27

169

Diarrhoea and gastroenteritis of presumed infectious origin

407

2540

1.45

11.27

1.1

249.41

255.55

mg/l

0.27

353

2227

Caries of dentine

132

674

1.92

11.13

1.1

271.44

305.84

mg/l

0.84

119

592

Disorders of lens

288

1149

1.57

11.05

1.1

301.04

308.70

mg/l

0.13

250

1004

Irregular menses

323

1691

1.51

11.00

1.1

208.54

219.52

mg/l

0.62

285

1471

Abnormal findings on examination of blood, without diagnosis

209

1155

1.67

10.96

1.0

1.1

252.51

303.73

mg/l

3.23

182

1020

Other and unspecified drugs and medicaments

242

2.59

10.93

1.1

231.98

262.36

mg/l

0.76

209

All influenza

139

748

1.87

10.91

1.1

256.14

265.20

mg/l

0.25

125

659

Other bacterial diseases

479

2294

1.41

10.88

1.1

335.13

263.49

mg/l

2.56

410

2023

Disorders of synovium and tendon

270

1518

1.56

10.81

1.1

256.03

267.33

mg/l

0.37

239

1324

Trochanteric bursitis

279

2.45

10.77

1.1

234.57

257.41

mg/l

0.46

239

Sicca syndrome [Sjögren]

193

2.77

10.70

1.2

1.1

203.32

241.08

mg/l

1.58

172

Disorders of choroid and retina

364

1761

1.47

10.68

1.1

287.21

288.29

mg/l

0.03

309

1559

Mixed connective tissue disease

166

2.93

10.66

1.1

263.41

250.78

mg/l

0.17

141

Covid-19 suspected case

153

856

1.80

10.63

1.1

281.74

236.86

mg/l

0.43

143

749

Undetermined asthma, excluding more controls

293

2.40

10.61

1.1

259.58

277.99

mg/l

0.32

255

Diseases of the skin and subcutaneous tissue

570

2088

1.37

10.59

1.1

256.56

260.95

mg/l

0.16

500

1853

Vitamin deficiency

110

3.41

10.56

1.1

208.31

226.07

mg/l

0.52

Vitamin deficiency, wide

110

3.41

10.56

1.1

208.31

226.07

mg/l

0.52

Deforming dorsopathies

138

749

1.85

10.56

1.1

243.61

244.48

mg/l

0.02

114

639

Undetermined asthma

294

2.39

10.53

1.1

259.58

276.20

mg/l

0.28

255

Cluster headache, wide,, including avohilmo

162

2.94

10.52

1.3

1.1

245.49

258.87

mg/l

0.26

135

Insomnia

507

2682

1.38

10.47

1.1

235.52

263.36

mg/l

1.34

439

2359

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

300

1973

1.50

10.32

1.1

265.98

267.45

mg/l

0.02

262

1740

Benign neoplasms

576

2341

1.36

10.29

1.1

247.80

258.34

mg/l

0.54

513

2038

Hypothyreosis and Thyroxine purchase for inclusion criteria

502

2388

1.38

10.27

1.1

239.21

257.05

mg/l

1.15

439

2092

External causes of morbidity and mortality

392

1351

1.46

10.23

1.1

256.39

263.09

mg/l

0.18

333

1186

Other enthesopathies

149

837

1.79

10.21

1.1

285.88

262.80

mg/l

0.34

128

724

Retinal detachments and breaks

142

787

1.81

10.17

1.1

305.91

289.53

mg/l

0.30

121

703

Pain and other conditions associated with female genital organs and menstrual cycle

158

830

1.76

10.10

1.1

203.11

206.64

mg/l

0.12

137

725

Hypothyroidism, other/unspecified

487

2320

1.38

10.05

1.1

237.86

256.70

mg/l

1.22

426

2032

Complications of surgical and medical care, not elsewhere classified

525

2639

1.37

10.05

1.1

255.34

268.70

mg/l

0.38

461

2310

Other and unspecified mononeuropathies, also in other diseases

4.67

10.03

1.2

1.1

234.61

243.22

mg/l

0.10

Infections with a predominantly sexual mode of transmission

288

1784

1.51

9.97

1.1

223.16

231.31

mg/l

0.32

253

1569

Other specified/unspecified systemic involvement of connective tissue

135

3.07

9.94

1.1

240.97

247.59

mg/l

0.08

118

Any death

248

1134

1.57

9.88

1.1

399.93

307.17

mg/l

1.20

217

997

Unspecific neurodegenerative disorder

120

425

1.93

9.86

1.1

270.00

326.76

mg/l

2.26

100

371

Explicit Sepsis

185

1038

1.67

9.85

1.1

370.44

274.21

mg/l

1.28

154

910

Zoster [herpes zoster]

220

1363

1.59

9.81

1.1

317.86

270.27

mg/l

0.92

188

1200

Hypertensive diseases

447

1802

1.40

9.78

1.1

273.07

266.29

mg/l

0.23

391

1589

Asthma, hospital admissions , main diagnosis only

452

2894

1.38

9.66

1.1

223.76

268.12

mg/l

6.10

395

2543

Other viral diseases

252

1631

1.54

9.66

1.1

249.43

236.85

mg/l

0.28

225

1435

Faecal incontinence

170

2.79

9.63

1.0

1.1

257.02

247.79

mg/l

0.12

152

Disorders of adult personality and behaviour

203

1262

1.62

9.60

1.1

207.36

237.42

mg/l

3.27

175

1119

Soft tissue disorders related to use, overuse and pressure

121

651

1.87

9.57

1.1

252.57

272.87

mg/l

0.59

107

557

Hypertension

445

1800

1.40

9.55

1.1

273.24

266.40

mg/l

0.23

390

1587

Disorders of psychological development

104

493

1.97

9.51

1.1

229.26

227.69

mg/l

0.02

425

Asthma, hospital admissions 3, pneumonia

165

973

1.70

9.49

1.1

238.73

264.32

mg/l

1.33

140

858

Asthma-related pneumonia or sepsis

165

973

1.70

9.49

1.1

238.73

264.32

mg/l

1.33

140

858

Asthma-related pneumonia

164

970

1.69

9.33

1.1

238.73

264.32

mg/l

1.32

140

856

Emotional disorders starting during childhood or adolecense, excluding more controls

147

2.89

9.32

1.0

160.53

220.19

mg/l

2.34

121

Hypothyroidism, drug reimbursement

276

2.16

9.31

1.1

226.97

213.70

mg/l

0.27

245

Hyperkinetic disorders, excluding more controls

449

2.02

9.25

1.1

199.79

229.11

mg/l

1.26

393

Other diseases of stomach and duodenum

125

3.07

9.24

1.1

1.0

258.00

309.71

mg/l

0.67

109

Other complications of surgical and medical care, not elsewhere classified

263

2.38

9.21

1.2

1.1

229.89

260.56

mg/l

0.87

230

Septicaemia

173

974

1.67

9.20

1.1

385.68

277.79

mg/l

1.41

145

865

Other bacterial diseases

530

2504

1.35

9.18

1.1

330.32

258.70

mg/l

2.76

455

2205

Myopia

472

2.01

9.18

1.1

226.44

240.15

mg/l

0.33

417

Post-traumatic stress disorder

333

2.21

9.17

1.1

194.57

224.13

mg/l

1.40

290

Other disorders of ear

456

2175

1.38

9.14

1.1

258.68

280.91

mg/l

1.25

408

1909

Inflammatory diseases of female pelvic organs

359

1852

1.43

9.14

1.1

219.56

225.80

mg/l

0.26

309

1622

Fitting and adjustment of other devices

126

627

1.82

9.08

1.1

345.02

296.90

mg/l

0.36

113

551

Acetic acid derivatives and related substances

138

392

1.83

9.08

1.1

267.59

271.14

mg/l

0.06

121

338

Other hearing loss

100

504

1.95

9.01

1.1

250.69

306.44

mg/l

2.43

444

Injuries to the ankle and foot

422

2729

1.38

8.95

1.1

251.90

253.25

mg/l

0.04

362

2407

Astigmatism

177

2.68

8.94

1.1

176.70

239.07

mg/l

2.26

146

Hypopituitarism

225

2.47

8.87

1.1

243.33

288.39

mg/l

0.78

192

Internal derangement of knee

197

1234

1.59

8.86

1.0

1.1

256.25

270.06

mg/l

0.55

174

1083

Benign neoplasm of brain and other parts of central nervous system

150

2.83

8.86

1.1

294.92

278.43

mg/l

0.17

128

Other diseases of pleura

167

880

1.67

8.85

1.0

1.1

394.14

302.13

mg/l

0.63

145

773

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

202

1265

1.59

8.85

1.1

211.14

221.01

mg/l

0.50

168

1114

Other viral diseases

193

1211

1.60

8.72

1.1

260.21

239.74

mg/l

0.38

170

1066

Use of levodopa decarboxylase inhibitor

233

2.42

8.69

1.2

1.1

354.76

311.11

mg/l

0.19

196

Disorders of the thyroid gland

505

2459

1.34

8.59

1.1

245.76

259.34

mg/l

0.76

444

2157

Injuries to the knee and lower leg

648

2775

1.30

8.57

1.1

271.19

262.63

mg/l

0.33

577

2429

Presence of other functional implants

218

970

1.56

8.54

1.1

307.84

307.47

mg/l

0.01

174

855

Speech and linguistic disorders

348

2.12

8.50

1.1

258.67

211.70

mg/l

0.75

301

Iridocyclitis

125

707

1.78

8.48

1.1

272.90

260.21

mg/l

0.19

106

622

Abnormal weight loss

218

2.45

8.46

1.1

288.28

278.91

mg/l

0.08

187

Personality disorders

188

1186

1.59

8.44

1.1

198.36

241.50

mg/l

6.64

163

1053

Generalized anxiety disorder

116

643

1.82

8.43

1.1

203.89

235.84

mg/l

2.45

108

569

Pneumonia, organism unspecified

473

2467

1.35

8.42

1.1

308.54

257.51

mg/l

1.61

410

2163

Intermittent heterotropia

207

2.49

8.37

1.1

217.86

228.69

mg/l

0.13

177

Bipolar affective disorders

122

688

1.78

8.37

1.1

234.12

246.25

mg/l

0.37

107

608

Other disorders of adrenal gland

122

2.99

8.37

1.2

1.1

400.92

238.02

mg/l

0.66

105

Nonorganic sleeping disorders

136

792

1.73

8.34

1.1

212.31

242.30

mg/l

1.87

118

694

Other specified/unspecified arthritis

140

822

1.71

8.32

1.1

343.57

260.28

mg/l

0.77

123

709

Polymyalgia rheumatica

202

2.49

8.28

1.0

269.34

310.92

mg/l

0.79

180

Specific personality disorders

164

1007

1.64

8.24

1.1

206.12

239.50

mg/l

3.54

140

889

Substance abuse, excluding more controls

257

1481

1.48

8.19

1.1

280.84

286.19

mg/l

0.10

230

1303

Convergent concomitant strabismus

186

2.56

8.16

1.1

224.19

242.98

mg/l

0.31

159

Carpal tunnel syndrome

267

1607

1.47

8.13

1.1

265.78

273.36

mg/l

0.26

238

1420

Non-allergic asthma (mode)

433

1.98

8.12

1.1

259.75

268.94

mg/l

0.12

376

Anterior Iridocyclitis

114

638

1.80

8.04

1.1

278.07

261.08

mg/l

0.24

560

Other arthritis (FG)

155

944

1.65

8.04

1.1

337.66

259.25

mg/l

0.81

137

815

Non-allergic asthma (mode), excluding more controls

435

1.97

8.02

1.1

259.75

268.94

mg/l

0.12

379

Senile cataract

232

935

1.52

7.97

1.1

311.37

313.38

mg/l

0.03

202

824

Chronic rhinitis, nasopharyngitis and pharyngitis

173

1085

1.60

7.97

1.1

238.43

247.88

mg/l

0.20

154

944

Injuries to the thorax

203

1320

1.54

7.96

1.1

341.61

277.09

mg/l

0.81

172

1176

Vestibular neuronitis

214

2.40

7.82

1.1

221.97

294.70

mg/l

2.83

180

Propionic acid derivatives

147

432

1.72

7.79

1.1

260.68

271.20

mg/l

0.21

125

377

Acute bronchitis

194

1235

1.54

7.68

1.1

275.26

257.81

mg/l

0.17

162

1095

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

1875

1.44

7.65

1.1

265.63

266.08

mg/l

0.01

236

1651

Retinal vascular occlusion

198

2.44

7.64

1.1

365.64

291.28

mg/l

0.71

169

Retinal vascular disorders

198

2.44

7.63

1.1

365.64

291.28

mg/l

0.71

169

Use of donepezil

224

2.31

7.62

1.1

266.88

309.99

mg/l

1.33

191

Paroxysmal tachycardia

117

557

1.76

7.60

1.1

237.65

258.98

mg/l

0.64

491

Other septicaemia

149

876

1.64

7.59

1.1

383.26

277.33

mg/l

1.13

126

781

Paracetamol or NSAID medication

246

1.95

7.54

1.1

256.72

267.64

mg/l

0.15

218

Diseases of male genital organs

244

823

1.50

7.51

1.1

300.84

344.20

mg/l

1.30

217

725

3.71

7.49

1.1

207.31

252.35

mg/l

1.01

Spondyloarthritis

460

1.90

7.38

1.1

254.56

266.17

mg/l

0.12

403

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

167

940

1.59

7.36

1.1

262.66

222.10

mg/l

0.28

140

835

Persistent mood disorders

102

569

1.80

7.31

1.1

274.91

263.28

mg/l

0.11

507

Inflammatory disease of uterus

100

555

1.81

7.31

1.0

1.1

227.49

207.04

mg/l

0.48

489

Complications of procedures, not elsewhere classified

406

2510

1.34

7.30

1.1

254.35

270.33

mg/l

0.37

359

2205

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

520

2733

1.30

7.28

1.1

296.85

260.69

mg/l

1.12

455

2399

Injury, poisoning and certain other consequences of external causes

314

1112

1.42

7.28

1.0

1.1

263.81

263.60

mg/l

0.00

268

982

Alzheimer disease

286

2.00

7.28

1.0

1.1

276.49

325.85

mg/l

1.13

250

Diseases of pulp and periapical tissues, including avohilmo

569

2288

1.29

7.19

1.1

245.62

271.91

mg/l

1.87

498

2012

Anti-inflammatory and antirheumatic products, non-steroids

144

432

1.68

7.13

1.1

256.82

271.20

mg/l

0.31

120

377

Other nutritional deficiencies

369

2576

1.35

7.12

1.1

232.60

259.25

mg/l

1.74

317

2268

Weight loss

251

2.21

6.99

1.1

285.16

271.05

mg/l

0.14

215

Acute and subacute iridocyclitis

104

593

1.76

6.95

1.1

283.53

260.20

mg/l

0.32

522

Disorders of mineral metabolism

195

2.38

6.94

1.2

1.1

268.82

262.38

mg/l

0.09

166

Pain associated with micturition

311

2.07

6.94

1.1

377.26

256.18

mg/l

0.48

263

Mycoses

134

819

1.64

6.93

1.1

276.68

262.80

mg/l

0.33

117

721

Other skin changes

414

1.92

6.92

1.2

1.1

275.19

281.39

mg/l

0.06

360

Infections with a predominantly sexual mode of transmission

213

1445

1.48

6.89

1.1

231.85

224.90

mg/l

0.24

192

1268

All pneumoniae

538

2804

1.28

6.89

1.1

294.35

258.64

mg/l

1.16

473

2457

Other and unspecified effects of external causes

170

1102

1.55

6.88

1.1

220.21

243.76

mg/l

1.16

146

976

Scleritis and episcleritis

172

2.47

6.85

1.0

1.1

259.59

247.36

mg/l

0.08

153

Tonsillectomy and adenotomy

389

2025

1.34

6.82

1.1

223.41

237.38

mg/l

0.70

344

1786

Disorders of speech understanding and production

146

2.59

6.78

1.2

1.1

247.97

201.50

mg/l

1.18

131

Pneumonias (Asthma/COPD co-morbidities)

532

2790

1.28

6.74

1.1

294.85

259.08

mg/l

1.14

467

2445

Tinnitus

111

651

1.71

6.73

1.1

233.54

274.35

mg/l

1.88

104

573

Injuries to the abdomen, lower back, lumbar spine and pelvis

186

1222

1.51

6.71

1.1

284.45

261.56

mg/l

0.42

164

1083

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

246

1079

1.44

6.60

1.1

239.29

247.10

mg/l

0.25

219

949

Disorders of skin appendages

272

1948

1.40

6.57

1.1

247.55

244.26

mg/l

0.08

238

1711

Hypothyroidism, strict autoimmune, 3 medication purchases required

432

2229

1.31

6.51

1.1

241.43

250.04

mg/l

0.41

380

1953

Poisoning by drugs, medicaments and biological substances

151

967

1.57

6.48

1.1

246.81

240.71

mg/l

0.17

128

859

All kidney diseases

518

2773

1.28

6.46

1.1

297.09

253.38

mg/l

1.38

452

2429

Other heart diseases, wide

522

2498

1.28

6.45

1.1

233.59

266.17

mg/l

3.19

452

2204

Other acute lower respiratory infections

256

1735

1.41

6.44

1.1

277.17

258.83

mg/l

0.23

216

1540

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.43

6.44

1.1

1.0

257.68

257.48

mg/l

0.00

Benign neoplasm of other and unspecified endocrine glands

341

1.98

6.43

1.1

254.85

266.28

mg/l

0.23

289

Other and unspecified mood [affective] disorders

254

2.14

6.41

1.1

202.04

230.78

mg/l

0.90

219

Chronic iridocyclitis

136

2.60

6.38

1.1

309.48

253.65

mg/l

0.24

116

Other predominantly sexually transmitted diseases, not elsewhere classified

152

979

1.56

6.38

1.1

236.56

222.05

mg/l

0.44

135

854

Early lumbar disc prolapse, operated

337

1.97

6.29

1.1

246.02

246.16

mg/l

0.00

292

Deviated nasal septum

149

957

1.56

6.28

1.1

295.92

302.00

mg/l

0.10

137

839

Other problems related to primary support group, including family circumstances

466

1.81

6.26

1.1

221.53

218.74

mg/l

0.06

412

Persons with potential health hazards related to communicable diseases

252

1784

1.40

6.26

1.1

252.47

232.98

mg/l

0.24

205

1580

Ménière disease

205

2.26

6.23

1.0

1.1

269.11

278.83

mg/l

0.14

175

Reimbursement for rheumatic diseases

274

1978

1.38

6.22

1.1

263.09

257.25

mg/l

0.15

241

1738

Superficial injury of abdomen, lower back and pelvis

495

1.79

6.22

1.1

278.95

256.96

mg/l

0.34

426

Other and unspecified coagulation defects

150

2.49

6.20

1.1

201.19

230.31

mg/l

0.69

128

Thyroiditis, ILD-related definition

291

2.04

6.19

1.2

1.1

211.36

233.95

mg/l

0.49

258

Other disorders of bone

113

683

1.66

6.17

1.0

1.1

212.03

255.98

mg/l

3.60

601

Hypokalaemia

258

2.10

6.16

1.1

294.17

264.33

mg/l

0.55

218

Unspecified/other endometriosis

411

1.86

6.12

1.1

191.17

209.94

mg/l

0.85

364

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

237

1675

1.41

6.10

1.1

261.47

239.85

mg/l

0.61

205

1484

Urticaria and erythema

206

1426

1.45

6.10

1.1

250.64

236.28

mg/l

0.35

176

1255

Oxicams

319

1.77

6.10

1.1

249.92

286.78

mg/l

1.26

272

Fracture of rib(s), sternum and thoracic spine

122

754

1.62

6.09

1.1

364.06

290.96

mg/l

0.54

102

661

Alzheimer disease, including avohilmo

344

1.80

6.09

1.0

1.1

278.04

325.68

mg/l

1.23

302

Other arrhythmias

328

1841

1.35

6.09

1.1

244.09

267.85

mg/l

1.35

274

1629

Volume depletion

170

2.37

6.04

1.1

257.31

275.95

mg/l

0.20

142

Alzheimer’s disease, strict definition

239

2.04

6.01

1.0

1.1

285.56

317.56

mg/l

0.55

208

Benign neoplasm of colon, rectum, anus and anal canal

230

1409

1.42

6.01

1.1

324.00

301.25

mg/l

0.44

213

1223

Poisoning by medicine

139

891

1.57

5.98

1.1

250.09

242.07

mg/l

0.21

117

787

Other disorders of eyelid

152

944

1.54

5.98

1.2

1.1

271.27

289.85

mg/l

0.49

131

818

Mycoses

443

3006

1.28

5.95

1.1

254.53

266.78

mg/l

0.62

392

2631

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

110

668

1.66

5.92

1.1

206.20

204.84

mg/l

0.04

589

Presbyopia

172

2.35

5.91

1.1

243.47

277.05

mg/l

0.74

154

Spondylolisthesis/Spondylolysis

387

1.87

5.90

1.1

255.18

256.36

mg/l

0.02

330

Disorders of conjunctiva

447

2803

1.28

5.89

1.1

246.33

257.40

mg/l

0.41

403

2460

Asthma/COPD (KELA code 203)

505

2739

1.27

5.87

1.1

247.25

267.60

mg/l

0.58

441

2411

Heartburn

277

2.03

5.85

1.1

219.17

265.19

mg/l

2.02

243

Other CVD (FINNGEN)

180

2.16

5.85

1.1

349.98

302.18

mg/l

0.33

154

Allergic asthma (mode)

132

825

1.57

5.76

1.1

223.59

236.46

mg/l

0.39

118

719

Allergic asthma (mode), excluding more controls

132

826

1.57

5.73

1.1

223.59

237.24

mg/l

0.42

118

719

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

169

1141

1.49

5.73

1.1

240.55

249.43

mg/l

0.26

142

1001

Episcleritis

150

2.42

5.71

1.0

1.1

270.95

247.65

mg/l

0.14

131

Polycystic ovarian syndrome, consortium definition

401

1827

1.30

5.71

1.1

217.58

225.90

mg/l

0.44

356

1590

Phobic anxiety disorders

523

1.73

5.69

1.1

210.44

240.65

mg/l

1.02

466

Early onset COPD, excluding more controls

370

1.87

5.69

1.2

1.1

390.34

310.09

mg/l

0.32

332

Pulmonary heart disease

109

667

1.64

5.69

1.1

344.86

278.83

mg/l

0.65

579

Pulmonary embolism

109

668

1.64

5.66

1.1

344.86

278.50

mg/l

0.65

580

Injuries to the shoulder and upper arm

392

2442

1.30

5.62

1.1

263.33

279.67

mg/l

0.77

346

2144

Social phobias

330

1.92

5.62

1.1

208.31

240.52

mg/l

1.20

290

Parkinson's disease

268

2.02

5.60

1.2

1.1

269.67

311.77

mg/l

0.79

229

Coagulation defects, purpura and other haemorrhagic conditions

102

617

1.66

5.60

1.1

251.73

256.51

mg/l

0.08

536

Behavioural disorders, excluding more controls

3.43

5.58

1.1

921.31

291.20

mg/l

0.44

Parkinson's disease, including avohilmo

282

1.99

5.58

1.2

1.1

267.32

315.06

mg/l

0.96

239

Emotionally unstable personality disorder

550

1.70

5.57

1.1

210.37

230.44

mg/l

0.95

480

Urticaria

174

1189

1.47

5.56

1.1

243.23

236.52

mg/l

0.13

147

1047

Other disorders of the genitourinary system

262

2.03

5.56

1.0

1.1

266.11

252.14

mg/l

0.23

229

Cerebral aneurysm, nonruptured

196

2.21

5.56

1.0

333.00

284.09

mg/l

0.21

173

Parkinson's disease, strict definition

242

2.08

5.55

1.2

1.1

276.30

313.49

mg/l

0.61

205

Fibroblastic disorders

446

1.78

5.55

1.1

280.06

283.17

mg/l

0.06

392

Menorrhagia

198

757

1.46

5.51

1.1

228.03

234.90

mg/l

0.19

172

664

Ovarian cyst

216

876

1.43

5.45

1.1

210.48

226.35

mg/l

0.66

192

763

Abnormal results of function studies

211

2.15

5.44

1.2

1.1

226.00

291.79

mg/l

1.48

183

Benign neoplasm: Colon

187

1241

1.44

5.43

1.1

332.67

307.59

mg/l

0.40

174

1078

Aneurysms, operations, SAH

349

1.87

5.38

1.0

1.1

318.79

291.27

mg/l

0.18

306

Oter anti-inflammatory and antirheumatic agents, non-steroids

252

1.80

5.38

1.1

273.03

306.64

mg/l

0.68

216

Glaucoma suspect

131

850

1.55

5.38

1.0

1.1

279.59

282.44

mg/l

0.05

112

739

Osteoporosis with pathological fracture (FG)

2.75

5.36

1.2

1.1

270.00

268.10

mg/l

0.01

Supplementary factors related to causes of morbidity and mortality classified elsewhere

160

1086

1.48

5.32

1.1

236.88

256.64

mg/l

0.92

140

956

Other coagulation defects

220

2.11

5.30

1.1

211.18

234.20

mg/l

0.52

189

Keratitis

177

1226

1.45

5.30

1.1

271.02

258.56

mg/l

0.33

151

1094

Disorders of lipoprotein metabolism and other lipidaemias

342

1614

1.31

5.28

1.1

304.58

290.49

mg/l

0.41

304

1426

Impingement syndrome of shoulder

528

1.69

5.27

1.1

329.76

284.59

mg/l

0.42

450

Excessive, frequent and irregular menstruation

235

925

1.40

5.22

1.1

200.93

221.69

mg/l

1.18

209

808

Other disorders of white blood cells

132

2.45

5.21

1.2

1.1

254.37

264.61

mg/l

0.11

114

Infections of the skin and subcutaneous tissue

300

2250

1.32

5.20

1.1

278.10

265.32

mg/l

0.31

261

1984

Candidiasis

151

1019

1.49

5.18

1.1

245.32

240.49

mg/l

0.13

132

897

Dislocation, sprain and strain of joints and ligaments of knee

333

2357

1.30

5.17

1.1

265.52

262.60

mg/l

0.08

299

2062

Schizophrenia or delusion, excluding more controls

142

937

1.50

5.16

1.0

1.1

220.49

269.72

mg/l

3.99

120

832

Calculus of kidney and ureter

124

803

1.55

5.16

1.1

272.73

284.32

mg/l

0.30

117

705

Other disorders of skin and subcutaneous tissue

296

1987

1.33

5.14

1.1

313.93

268.92

mg/l

0.76

248

1757

Adhesive capsulitis of shoulder

326

1.88

5.14

1.1

258.67

272.04

mg/l

0.22

280

Congenital malformations, deformations and chromosomal abnormalities

366

2627

1.29

5.10

1.1

241.93

251.31

mg/l

0.33

330

2303

Sensorineural hearing loss

289

1471

1.34

5.09

1.1

278.16

297.73

mg/l

0.66

254

1290

Diabetic neuropathy

196

2.14

5.08

1.1

290.03

312.88

mg/l

0.29

167

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

142

951

1.50

5.06

1.1

261.10

262.97

mg/l

0.04

125

844

Suicide or other Intentional self-harm

144

968

1.49

5.05

1.1

252.47

246.48

mg/l

0.16

125

856

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

500

2620

1.24

5.04

1.1

265.51

260.16

mg/l

0.19

437

2301

Congenital malformations, deformations and chromosomal abnormalities

340

2504

1.30

5.04

1.1

243.29

248.03

mg/l

0.14

308

2196

Venous thromboembolism

204

1412

1.40

5.04

1.1

305.90

288.52

mg/l

0.24

184

1236

Disorders of vitreous body and globe

187

1269

1.42

5.01

1.1

279.01

286.41

mg/l

0.20

171

1107

Problems related to lifestyle

351

1.83

5.00

1.2

1.1

224.17

258.35

mg/l

1.22

306

Pulmonary heart disease, diseases of pulmonary circulation

113

722

1.57

4.99

1.2

1.1

342.37

285.80

mg/l

0.54

101

631

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

160

2.26

4.98

1.0

1.1

228.31

295.99

mg/l

1.70

138

Ganglion

100

622

1.61

4.96

1.1

256.64

242.85

mg/l

0.25

534

Drug-induced adrenocortical insufficiency

3.54

4.92

1.3

1.1

298.50

216.46

mg/l

—

Disorders of vitreous body

182

1241

1.42

4.91

1.1

281.41

287.09

mg/l

0.14

167

1080

Diseases of the digestive system

183

1291

1.41

4.85

1.1

257.20

271.06

mg/l

0.41

162

1144

Spondylopathies (FG)

458

1.71

4.84

1.1

252.07

259.34

mg/l

0.07

394

Urolithiasis

128

848

1.51

4.82

1.1

297.28

291.27

mg/l

0.07

120

746

Adverse effects, not elsewhere classified

113

729

1.56

4.82

1.1

214.04

238.74

mg/l

0.89

638

Caries of enamel

479

2791

1.24

4.78

1.1

255.70

263.58

mg/l

0.14

434

2447

Diaphragmatic hernia

135

906

1.49

4.78

1.1

273.14

286.54

mg/l

0.15

123

784

Anomalies of pupillary function

3.21

4.78

1.0

1.1

218.50

233.43

mg/l

0.19

Other predominantly sexually transmitted diseases, not elsewhere classified

118

771

1.54

4.77

1.1

247.53

225.85

mg/l

0.58

108

674

Persons encountering health services for specific procedures, not carried out

244

1.98

4.73

1.2

1.1

271.23

261.14

mg/l

0.08

207

Agranulocytosis

279

1.91

4.72

1.1

443.29

264.16

mg/l

0.62

244

Procreative management

201

1210

1.39

4.70

1.1

251.36

257.42

mg/l

0.09

183

1053

Conjunctivitis

407

2709

1.26

4.68

1.1

234.32

253.39

mg/l

1.03

370

2375

Other and unspecified disorders of vitreous body

147

994

1.46

4.68

1.1

280.74

285.26

mg/l

0.09

133

869

Noninfective enteritis and colitis

232

1721

1.35

4.65

1.0

1.1

262.43

254.06

mg/l

0.19

200

1524

Other retinal disorders

236

1362

1.35

4.65

1.1

286.64

291.29

mg/l

0.13

203

1211

Unspecified fall

222

1614

1.36

4.64

1.1

254.56

262.47

mg/l

0.21

188

1422

Decubitus ulcer and pressure area

2.59

4.64

1.1

1.0

767.89

282.30

mg/l

0.67

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

244

1150

1.35

4.63

1.1

188.08

196.07

mg/l

0.57

221

996

Vasomotor and allergic rhinitis

208

1493

1.37

4.61

1.1

229.07

247.19

mg/l

0.70

183

1299

DVT of lower extremities and pulmonary embolism

151

1040

1.45

4.60

1.1

324.52

281.84

mg/l

0.54

136

912

Haemorrhage from respiratory passages

122

728

1.51

4.57

1.0

1.1

266.39

299.81

mg/l

0.87

108

645

Diseases of pulp and periapical tissues and dental caries

309

1211

1.31

4.55

1.1

262.02

294.82

mg/l

1.37

260

1075

Abnormal blood-pressure reading, without diagnosis

110

2.47

4.55

1.1

226.86

299.93

mg/l

1.65

Meniscus derangement

238

1192

1.35

4.50

1.1

280.11

285.52

mg/l

0.11

209

1037

Secondary and unspecified malignant neoplasm of lymph nodes

174

2.14

4.49

1.1

339.94

265.81

mg/l

0.64

150

Disturbance of activity and attention

565

1.60

4.47

1.1

200.33

222.24

mg/l

0.84

493

Other obstetric conditions, not elsewhere classified

247

1175

1.34

4.47

1.1

188.73

197.09

mg/l

0.61

223

1017

Pure hypercholesterolaemia

284

1414

1.31

4.47

1.1

320.65

295.17

mg/l

0.75

256

1244

Other viral diseases, not elsewhere classified

155

1079

1.43

4.46

1.1

246.68

238.11

mg/l

0.14

142

949

Conductive and sensorineural hearing loss

311

1623

1.29

4.45

1.1

273.56

295.12

mg/l

0.82

274

1426

Methotrexate

350

1.78

4.44

1.0

1.1

233.36

264.07

mg/l

0.79

310

Sudden idiopathic hearing loss

229

1.98

4.44

1.0

1.1

259.10

297.59

mg/l

0.66

198

Other and unspecified tonsillitis

216

1345

1.35

4.35

1.1

240.21

243.63

mg/l

0.08

190

1182

Chronic apical periodontitis

577

2724

1.21

4.35

1.1

247.77

267.07

mg/l

1.38

513

2383

Polyarthropathies

320

1628

1.29

4.33

1.1

319.41

265.48

mg/l

1.13

285

1423

Use of rivastigmine

176

2.10

4.33

1.0

1.1

243.45

301.38

mg/l

1.46

149

Other disorders starting during childhood or adolecense, excluding more controls

150

2.19

4.33

1.1

189.45

221.26

mg/l

0.60

127

Lung cancer and mesothelioma

226

1.90

4.32

1.0

1.1

358.02

320.14

mg/l

0.45

197

Type of accident

143

995

1.44

4.27

1.1

234.12

256.59

mg/l

1.09

124

876

Glaucoma

187

1170

1.38

4.24

1.1

313.43

293.48

mg/l

0.39

159

1018

Acute pharyngitis

619

1.56

4.24

1.1

235.49

244.86

mg/l

0.19

549

Spinal instabilities

2.93

4.18

1.0

242.67

261.58

mg/l

0.17

Dementia in Alzheimer disease

144

2.12

4.17

1.0

268.11

324.28

mg/l

1.09

124

Emotional disorders starting during childhood or adolescence

219

1.96

4.16

1.0

1.1

160.53

204.15

mg/l

1.62

190

Endometriosis

196

839

1.37

4.11

1.1

225.20

228.81

mg/l

0.09

166

737

Other noninfective gastroenteritis and colitis

117

791

1.48

4.06

1.0

1.1

267.23

253.58

mg/l

0.18

106

695

Other CVD

353

1.73

4.04

1.1

347.32

296.45

mg/l

0.46

302

Conjunctivitis (acute, non atopic)

148

1044

1.42

4.04

1.1

259.55

244.41

mg/l

0.43

138

913

Sequelae of injuries, of poisoning and of other consequences of external causes

118

801

1.48

4.04

1.0

1.1

308.28

268.96

mg/l

0.26

104

705

Chronic gastritis

561

1.57

4.02

1.0

1.1

281.19

288.00

mg/l

0.07

493

Contact with and exposure to communicable diseases

203

1509

1.34

4.01

1.1

210.61

224.85

mg/l

0.70

165

1336

Diseases of liver

143

1008

1.42

4.01

1.1

248.30

274.15

mg/l

1.25

119

897

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

325

1.76

3.99

1.1

341.72

284.31

mg/l

0.70

288

Inflammatory diseases of prostate (prostatitis)

267

1.84

3.98

1.0

1.1

285.81

336.61

mg/l

1.33

235

Atopic dermatitis

333

2174

1.26

3.93

1.1

217.38

241.95

mg/l

1.79

291

1918

Diseases of tongue

144

2.17

3.92

1.1

240.27

292.44

mg/l

1.11

122

Ehlers-Danlos syndrome

3.87

3.92

1.0

1.1

213.43

219.62

mg/l

0.07

Sequelae of injuries of upper limb

283

1.81

3.92

1.1

242.68

285.28

mg/l

1.09

243

Emotional disorders and disorders of social functioning with onset specific to childhood

243

1.88

3.92

1.0

1.1

164.06

217.54

mg/l

2.08

210

Rash and other nonspecific skin eruption

233

1.90

3.91

1.1

223.00

275.55

mg/l

1.63

206

Hypotension

283

1.81

3.91

1.1

361.44

304.27

mg/l

0.43

238

Car occupant injured in other and unspecified transport accidents

108

726

1.49

3.90

1.1

297.09

248.46

mg/l

0.32

101

632

Other cataract

148

793

1.41

3.90

1.1

320.91

294.42

mg/l

0.34

131

705

Dermatographic urticaria

227

1.91

3.87

1.0

1.1

199.64

226.39

mg/l

0.66

196

Appendectomy

341

2615

1.25

3.87

1.1

235.61

256.93

mg/l

1.49

299

2298

Hyperplasia of prostate

117

446

1.49

3.85

1.1

341.66

375.92

mg/l

0.59

100

391

Missing teeth due to accident, extraction or parodontitis

221

1582

1.32

3.85

1.1

293.40

292.43

mg/l

0.02

196

1384

Fall on and from stairs and steps

118

810

1.46

3.83

1.1

287.97

258.72

mg/l

0.46

710

Fenamates

265

1.70

3.81

1.1

238.25

271.23

mg/l

0.82

227

Hyperkinetic disorders

604

1.53

3.80

1.1

199.79

217.84

mg/l

0.70

523

Arthrosis

318

1378

1.27

3.80

1.1

255.52

276.12

mg/l

1.37

280

1201

Convergence insufficiency and excess

3.24

3.80

1.3

1.1

197.79

202.23

mg/l

0.06

Injury of muscle and tendon at shoulder and upper arm level

129

903

1.43

3.78

1.1

303.69

313.22

mg/l

0.17

118

800

Dental caries, including avohilmo

332

1347

1.26

3.78

1.1

263.13

290.03

mg/l

1.12

282

1197

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

308

1934

1.26

3.77

1.1

216.88

238.54

mg/l

1.53

269

1694

Lung diseases due to external agents

259

1.82

3.70

1.1

427.29

307.23

mg/l

0.33

217

Superficial injury of head

107

726

1.48

3.70

1.1

277.68

258.13

mg/l

0.44

643

Injury of nerves at wrist and hand level

109

2.31

3.69

1.1

211.45

259.43

mg/l

0.99

Other and unspecified iron deficiency

133

940

1.42

3.69

1.1

274.77

257.37

mg/l

0.28

115

827

Other and unspecified urticaria

107

727

1.48

3.68

1.1

273.36

240.85

mg/l

0.53

638

Flat foot [pes planus] (acquired)

224

1.88

3.67

1.1

239.86

251.27

mg/l

0.25

198

Superficial injury of lower leg

126

884

1.43

3.67

1.1

231.44

245.56

mg/l

0.51

110

774

False labour

207

972

1.33

3.65

1.1

184.55

211.10

mg/l

2.69

186

844

Melanocytic naevi of trunk

380

1.67

3.65

1.1

269.51

258.57

mg/l

0.20

329

Glomerular diseases

490

1.58

3.59

1.1

280.39

282.94

mg/l

0.03

419

Other and unspecified anaemias

135

916

1.41

3.59

1.1

325.54

287.17

mg/l

0.44

103

814

Unspecified haematuria

139

822

1.40

3.59

1.1

392.98

293.75

mg/l

0.94

130

721

Other bacterial intestinal infections

451

1.60

3.59

1.1

488.95

279.48

mg/l

0.96

388

Congenital iodine-deficiency syndrome/hypothyroidism

2.97

3.58

1.4

1.1

241.33

224.31

mg/l

0.15

All influenza (not pneumonia)

468

1.59

3.55

1.1

253.94

272.85

mg/l

0.40

403

Herpesviral [herpes simplex] infections

131

932

1.41

3.54

1.1

255.02

231.76

mg/l

0.58

118

824

Unspecified urinary incontinence

178

1.98

3.53

1.1

341.52

260.84

mg/l

0.46

151

Diseases of oral cavity, salivary glands and jaws

257

1026

1.29

3.52

1.1

261.02

299.08

mg/l

1.68

223

892

Malignant melanoma of skin, including Hilmo

286

1.75

3.51

1.1

494.40

276.18

mg/l

0.70

253

Malignant melanoma, including Hilmo

348

1.67

3.44

1.1

487.29

284.51

mg/l

0.80

312

Other anaemias

136

930

1.39

3.43

1.1

324.72

289.04

mg/l

0.40

104

826

Obesity and other hyperalimentation

325

2537

1.24

3.42

1.0

1.1

237.93

257.43

mg/l

0.96

286

2223

Behavioural disorders

2.53

3.39

1.1

921.31

219.74

mg/l

0.50

Iron deficiency anaemia

163

1195

1.35

3.35

1.1

273.34

259.59

mg/l

0.25

137

1053

Sequelae of external causes of morbidity and mortality

102

701

1.46

3.35

1.1

340.23

267.94

mg/l

0.42

610

Open wound of wrist and hand

219

1661

1.29

3.34

1.1

260.57

272.00

mg/l

0.36

189

1471

Ischemic heart diseases

340

1656

1.23

3.33

1.1

261.83

298.68

mg/l

2.26

291

1463

Hyperlipidaemia, other/unspecified

123

805

1.41

3.32

1.1

325.88

317.22

mg/l

0.15

706

Aplastic and other anaemias

148

1012

1.37

3.32

1.1

325.07

286.87

mg/l

0.48

114

894

Secondary hypertension

173

1.95

3.31

1.0

1.1

272.42

270.79

mg/l

0.01

151

Diseases of external ear

146

1071

1.37

3.31

1.1

261.26

262.81

mg/l

0.04

132

947

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

695

1.46

3.31

1.1

245.78

243.36

mg/l

0.05

613

Diseases of middle ear and mastoid

324

2151

1.23

3.31

1.1

251.81

244.47

mg/l

0.24

283

1893

Mouth breathing

173

1303

1.33

3.28

1.1

286.72

283.28

mg/l

0.07

139

1159

Ankylosing spondylitis

219

1.83

3.27

1.1

300.32

262.45

mg/l

0.20

184

Asthma and allergy, excluding more controls

464

1.56

3.27

1.1

224.24

226.92

mg/l

0.04

403

Misadventures to patients during surgical and medical care

377

1.62

3.25

1.1

244.91

261.71

mg/l

0.36

327

Asthma and allergy

465

1.55

3.24

1.1

224.24

225.47

mg/l

0.02

403

Drug-induced neutropenia

170

1.95

3.24

1.1

577.67

266.91

mg/l

0.66

148

Conduct disorder

2.47

3.23

1.1

921.31

250.21

mg/l

0.47

Obesity

322

2533

1.23

3.22

1.0

1.1

238.38

256.68

mg/l

0.87

283

2219

Other metabolic disorders

417

1.59

3.22

1.1

205.98

232.26

mg/l

0.98

365

Pruritus

287

1.71

3.20

1.1

295.49

246.51

mg/l

0.49

249

Vascular dementia

2.33

3.20

1.2

1.0

274.76

321.36

mg/l

0.67

Orchitis and epididymitis

199

1.87

3.19

1.1

295.22

342.86

mg/l

0.69

176

Other inflammation of eyelid

341

1.65

3.17

1.1

245.92

261.22

mg/l

0.35

290

Exclusions for E4_PCOS_CONSORTIUM

389

2017

1.21

3.16

1.1

231.32

232.93

mg/l

0.07

334

1765

Melanocytic naevi

142

1048

1.36

3.13

1.1

260.33

246.53

mg/l

0.39

121

919

Hernia of abdominal wall, postoperative

381

1.61

3.12

1.1

348.90

270.75

mg/l

0.58

341

Maltreatment syndromes

201

1.85

3.12

1.2

1.1

207.86

254.45

mg/l

1.08

168

Complications of internal orthopaedic prosthetic devices, implants and grafts

444

1.56

3.12

1.0

1.1

291.74

295.33

mg/l

0.06

387

Acute lymphadenitis

202

1.84

3.07

1.2

1.1

209.67

256.78

mg/l

1.22

173

Divergent concomitant strabismus

224

1.80

3.06

1.1

232.77

267.63

mg/l

0.47

192

Diseases of appendix

369

2764

1.20

3.05

1.1

264.68

266.43

mg/l

0.03

318

2437

Leisure time condition

584

1.48

3.04

1.1

235.59

262.48

mg/l

0.86

507

Other pleural conditions

174

1.90

3.04

1.0

1.1

233.89

305.25

mg/l

1.71

146

Bacterial intestinal infections, IBD co-morbidities

455

1.54

3.04

1.1

493.28

280.18

mg/l

0.94

390

L04AC Interleukin inhibitors

189

1.86

3.01

1.1

209.99

273.83

mg/l

1.87

158

Tongue abnormality

133

2.04

3.01

1.1

241.00

272.40

mg/l

0.48

112

Assault by bodily force

308

1.67

3.01

1.2

1.1

245.20

260.65

mg/l

0.23

271

Caries of dentine, including avohilmo

356

1496

1.22

3.01

1.1

267.02

281.45

mg/l

0.50

304

1334

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

113

2.14

3.00

1.1

231.92

262.32

mg/l

0.50

Other viral diseases, not elsewhere classified

100

700

1.43

2.98

1.2

1.1

262.12

247.75

mg/l

0.15

614

Cardiodefibrillation

732

0.60

2.98

1.1

280.14

324.99

mg/l

1.47

647

Appendicitis, broad definition

366

2758

1.20

2.96

1.1

264.19

266.61

mg/l

0.04

315

2431

Malignant melanoma

279

1.69

2.95

1.1

341.76

278.31

mg/l

0.69

246

Budesonide

419

1.56

2.94

1.0

1.1

237.59

259.01

mg/l

0.57

371

Excessive attrition of teeth

287

2343

1.23

2.90

1.1

238.80

252.70

mg/l

0.68

247

2060

Acute tubulo-interstitial nephritis

269

1878

1.24

2.90

1.1

323.29

255.04

mg/l

1.13

237

1644

Assault

566

1.47

2.90

1.1

238.25

256.06

mg/l

0.42

499

Dental operations

258

1058

1.25

2.89

1.1

261.53

292.18

mg/l

1.28

222

939

Monoamine oxidase A inhibitors

267

1.69

2.84

1.0

1.1

222.16

284.87

mg/l

2.79

238

Other diseases of liver

512

1.49

2.82

1.1

222.44

271.53

mg/l

2.26

449

Other female pelvic inflammatory diseases

496

1.50

2.82

1.1

218.24

220.73

mg/l

0.04

441

Other disorders of conjunctiva

306

1.64

2.81

1.1

344.84

279.19

mg/l

0.49

262

Other disorders of glucose regulation and pancreatic internal secretion

238

1.73

2.81

1.1

248.27

277.40

mg/l

0.54

200

Explicit bacterial Sepsis

223

1.75

2.80

1.2

1.1

539.38

299.35

mg/l

0.64

193

Superficial injury of wrist and hand

109

787

1.39

2.80

1.1

300.20

241.38

mg/l

0.40

693

Dialysis, with operation codes

330

1.61

2.79

1.2

1.1

361.84

311.78

mg/l

0.68

281

Streptococcal septicaemia

187

1.83

2.78

1.2

1.1

563.52

297.44

mg/l

0.60

163

Other conditions related to polyarteritis nodosa

8.72

2.78

1.0

1.2

249.80

251.50

mg/l

—

Obesity due to excess calories

241

1942

1.24

2.78

1.0

1.1

240.57

248.10

mg/l

0.22

210

1699

Other disorders of skin and subcutaneous tissue, not elsewhere classified

362

1.58

2.77

1.1

276.88

274.11

mg/l

0.04

311

Dermatophytosis

323

1.62

2.77

1.1

272.74

299.70

mg/l

0.50

274

Purpura and other haemorrhagic conditions

378

1.57

2.76

1.2

1.1

273.60

279.29

mg/l

0.06

319

Disorders of orbit

104

2.13

2.75

1.2

1.1

320.75

251.52

mg/l

0.52

Diseases of salivary glands

141

1063

1.33

2.75

1.2

1.1

233.68

253.14

mg/l

0.89

122

933

Postprocedural endocrine and metabolic disorders, not elsewhere classified

380

1.56

2.71

1.2

1.1

211.02

230.64

mg/l

0.59

331

Hypoglycaemia, other or unspecified

189

1.81

2.70

1.1

241.78

274.38

mg/l

0.64

160

Fracture at wrist and hand level

164

1264

1.30

2.69

1.1

308.15

270.65

mg/l

0.78

142

1127

Renal tubulo-interstitial diseases

391

2460

1.18

2.67

1.1

316.40

253.92

mg/l

1.60

340

2156

Glomerulonephritis

257

1.68

2.67

1.1

279.02

292.54

mg/l

0.14

219

Nephropathy related operations

311

1.61

2.66

1.2

1.1

372.24

304.70

mg/l

0.96

264

Bacterial pneumonia (organism specified)

163

1141

1.30

2.65

1.2

1.1

351.66

270.58

mg/l

0.89

148

1017

Other bacterial intestinal infections

653

1.41

2.62

1.1

444.91

264.76

mg/l

1.03

574

Malignant neoplasm of breast, including Hilmo

104

924

0.73

2.62

1.2

1.1

290.40

240.24

mg/l

0.63

807

Malignant neoplasm of breast, HER2-negative, including Hilmo

104

924

0.73

2.62

1.2

1.1

290.40

240.24

mg/l

0.63

807

Crohn's disease of small intestine

236

1.70

2.61

1.0

1.1

231.50

274.12

mg/l

0.82

202

Malignant neoplasm of digestive organs

637

0.64

2.60

1.1

396.96

292.82

mg/l

1.02

568

Bleeding

326

1933

1.20

2.59

1.1

307.95

278.28

mg/l

0.56

292

1700

Endometriosis of pelvic peritoneum

617

1.41

2.56

1.1

204.05

217.84

mg/l

0.58

541

Acute appendicitis

343

2697

1.19

2.56

1.1

266.45

266.73

mg/l

0.00

297

2376

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

245

1.68

2.56

1.1

283.97

277.29

mg/l

0.09

210

Fall on same level involving ice and snow

245

1998

1.23

2.56

1.1

281.39

260.15

mg/l

0.53

210

1772

Other superficial mycoses

394

1.53

2.55

1.2

1.1

229.58

252.70

mg/l

0.56

339

Sequelae with surgical and medical care as external cause

516

1.46

2.54

1.1

362.74

276.41

mg/l

0.39

447

Nutritional anaemias

180

1367

1.27

2.53

1.1

275.37

264.04

mg/l

0.21

150

1203

Malignant neoplasm of breast, HER2-negative

881

0.73

2.51

1.2

1.1

294.87

241.46

mg/l

0.64

767

Ovarian dysfunction

356

1.55

2.51

1.0

1.1

190.62

196.17

mg/l

0.19

312

Acute appendicitis, no complications

281

2318

1.21

2.50

1.1

230.08

256.64

mg/l

2.12

244

2037

Open wound of head

212

1644

1.24

2.50

1.1

304.04

283.15

mg/l

0.34

186

1454

Ehlers-Danlos syndrome

3.52

2.49

1.0

1.2

197.11

231.48

mg/l

—

Nontraumatic intracranial haemmorrhage

348

1.55

2.49

1.1

366.88

308.78

mg/l

0.93

303

Retinal detachment with retinal break

270

1.63

2.49

1.1

265.28

306.34

mg/l

1.02

236

Fracture of lower leg, including ankle

234

1886

1.23

2.48

1.1

291.57

273.25

mg/l

0.41

209

1660

Secondary uncertain malignant neoplasm

255

1.65

2.47

1.1

357.97

281.77

mg/l

0.66

224

Coeliac disease

389

1.52

2.47

1.2

1.1

258.90

255.97

mg/l

0.03

339

Rheumatoid arthritis

117

782

1.34

2.47

1.1

287.88

267.66

mg/l

0.29

104

678

Anogenital herpesviral [herpes simplex] infection

479

1.47

2.46

1.1

204.44

217.98

mg/l

0.50

413

Malignant neoplasm of breast

101

897

0.73

2.45

1.2

1.1

290.60

241.90

mg/l

0.58

781

Myeloid leukaemia

2.57

2.45

1.3

1.1

236.15

244.73

mg/l

0.07

COPD (mode)

432

1.44

2.44

1.2

1.1

393.25

316.16

mg/l

0.36

383

Bacterial, viral and other infectious agents

319

1.57

2.43

1.1

249.77

273.60

mg/l

0.48

276

Other diseases of arteries and capillaries

204

1.72

2.40

1.1

357.67

284.78

mg/l

0.29

175

DVT of lower extremities

424

1.49

2.40

1.1

265.84

276.92

mg/l

0.17

368

Intracerebral haemorrhage

204

1.72

2.40

1.1

400.83

299.44

mg/l

1.37

173

Other keratitis

384

1.52

2.40

1.1

265.90

261.47

mg/l

0.04

335

Enterocolitis due to Clostridium difficile

227

1.68

2.39

1.1

633.52

294.12

mg/l

0.77

194

Gonarthrosis [arthrosis of knee](FG)

287

1383

1.21

2.38

1.1

271.17

292.25

mg/l

0.96

253

1202

Lagophthalmos

3.68

2.37

1.4

1.0

264.25

246.14

mg/l

—

Other and unspecified acne

2.64

2.37

1.7

1.1

166.88

224.77

mg/l

1.90

Other/unspecified cytomegaloviral diseases

2.64

2.37

1.2

1.1

331.75

238.59

mg/l

0.69

Bacterial pneumonia, not elsewhere classified

141

957

1.30

2.36

1.2

1.1

365.26

271.74

mg/l

0.90

129

846

Perforation of tympanic membrane

290

1.59

2.36

1.1

277.93

275.32

mg/l

0.02

250

Vascular dementia (subcortical)

3.05

2.36

1.1

1.0

306.80

254.61

mg/l

—

Alcohol abuse, main dg, excluding more controls

402

1.50

2.35

1.2

1.1

223.65

283.18

mg/l

3.33

355

Lateral epicondylitis

314

1.56

2.34

1.1

344.95

270.57

mg/l

0.39

266

Nail disorders

244

1.65

2.34

1.1

274.85

276.47

mg/l

0.01

204

Other diseases of anus and rectum

106

787

1.35

2.31

1.1

262.45

278.64

mg/l

0.36

679

Heart failure, not strict

272

1532

1.21

2.31

1.2

1.1

274.11

298.75

mg/l

1.04

238

1344

Superficial injury of thorax

420

1.48

2.31

1.1

430.48

277.71

mg/l

0.60

359

Torticollis

2.78

2.28

1.2

1.1

280.00

232.34

mg/l

0.21

Crohn disease (strict definition, all UC cases excluded)

163

1.79

2.27

1.0

1.1

219.54

267.31

mg/l

0.79

138

Abnormal findings on antenatal screening of mother

447

1.46

2.26

1.1

190.16

192.79

mg/l

0.06

387

Substance abuse

257

2006

1.21

2.26

1.1

280.84

280.89

mg/l

0.00

230

1769

Unspecified mental disorder

199

1612

1.24

2.26

1.0

1.1

227.54

256.63

mg/l

1.77

170

1426

Superficial injury of hip and thigh

349

1.52

2.25

1.1

217.71

279.85

mg/l

2.64

293

Haemorrhoids and perianal venous thrombosis

110

825

1.33

2.25

1.1

301.19

278.55

mg/l

0.26

102

715

Autoimmune hyperthyroidism

120

1.92

2.25

1.2

1.1

286.00

244.97

mg/l

0.42

107

Disease of hard tissues of teeth, NOS

238

1018

1.22

2.25

1.1

248.93

299.92

mg/l

2.85

214

885

Dermatitis due to substances taken internally

142

1.84

2.23

1.0

259.42

245.90

mg/l

0.11

122

Chronic kidney disease

578

1.39

2.22

1.0

1.1

320.63

309.05

mg/l

0.17

498

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

279

1.58

2.22

1.1

311.11

256.12

mg/l

0.23

236

Other and unspecified nonorganic psychotic disorders

109

821

1.33

2.22

1.0

1.1

219.22

259.12

mg/l

1.57

729

Candidiasis

416

1.47

2.21

1.1

279.98

253.12

mg/l

0.45

361

Thrombocytopenia, unspecified

172

1.75

2.20

1.1

361.70

277.19

mg/l

0.72

150

Gonarthrosis

245

1149

1.22

2.20

1.1

266.17

287.14

mg/l

0.93

219

992

All chronic kidney diseases

196

1297

1.24

2.20

1.1

283.58

274.84

mg/l

0.25

168

1142

Viral warts

107

805

1.33

2.20

1.1

242.41

245.83

mg/l

0.07

705

Disorders of breast

230

1721

1.21

2.19

1.1

245.04

231.27

mg/l

0.26

199

1511

Endometriosis diagnosis and infertility diagnosis occurring together

450

1.45

2.19

1.1

207.76

206.47

mg/l

0.04

397

Other arthrosis

194

1084

1.24

2.19

1.0

1.1

264.29

292.89

mg/l

1.36

169

940

Other noninflammatory disorders of vulva and perineum

304

1.55

2.18

1.1

225.88

214.64

mg/l

0.15

268

Anomalies of dental arch relationship, including avohilmo

107

725

1.33

2.18

1.0

1.1

220.08

238.03

mg/l

0.36

638

Gingivitis and periodontal diseases

485

2182

1.15

2.17

1.1

250.67

272.41

mg/l

1.47

432

1917

Other contact dermatitis

234

1.63

2.16

1.1

1.0

269.18

268.21

mg/l

0.01

206

Female infertility, associated with anovulation

394

1.48

2.16

1.1

194.75

204.46

mg/l

0.21

344

Mental and behavioural disorders due to psychoactive substance use

264

2047

1.20

2.16

1.1

280.65

279.38

mg/l

0.02

234

1803

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.32

2.16

1.0

1.1

213.43

198.65

mg/l

0.22

Chondropathies

518

1.41

2.15

1.1

206.26

257.86

mg/l

3.32

450

Congenital malformations and deformations of the musculoskeletal system

433

1.45

2.14

1.1

194.72

229.64

mg/l

0.54

378

Otitis externa

100

748

1.34

2.14

1.1

238.86

255.41

mg/l

0.57

657

Fissure and fistula of anal and rectal regions

100

748

1.34

2.14

1.1

281.19

273.49

mg/l

0.15

653

Childhood asthma (age<16), excluding more controls

467

1.39

2.11

1.2

1.1

235.87

220.93

mg/l

0.20

402

Striking against or struck by other objects

163

1303

1.25

2.10

1.1

322.77

267.55

mg/l

0.54

138

1160

Rosacea

348

1.50

2.08

1.1

222.21

245.82

mg/l

0.66

305

Atrial fibrillation and flutter with reimbursement

381

1.39

2.08

1.1

389.51

291.13

mg/l

0.47

336

Colour vision deficiencies

5.11

2.08

1.0

1.1

184.80

240.50

mg/l

—

Other diseases of oesophagus

198

1.67

2.08

1.1

237.54

298.84

mg/l

2.18

167

Other diseases of hard tissues of teeth

240

1026

1.21

2.07

1.1

266.42

299.08

mg/l

1.24

208

892

Adenomyosis (Endometriosis of uterus)

398

1.46

2.06

1.1

1.0

220.51

229.61

mg/l

0.25

351

Other bursopathies

253

1.58

2.06

1.0

1.1

264.68

278.92

mg/l

0.18

212

Acute generalized exanthematous pustulosis

110

1.92

2.06

1.0

1.1

277.13

247.37

mg/l

0.22

Bacterial pneumoniae

148

1033

1.26

2.05

1.2

1.1

356.31

272.34

mg/l

0.83

136

913

Congenital malformations of the circulatory system

491

1.41

2.05

1.1

239.38

262.11

mg/l

0.60

430

Childhood asthma (age<16)

470

1.38

2.05

1.2

1.1

235.87

220.38

mg/l

0.21

404

Hallux rigidus

277

1.56

2.05

1.0

1.1

315.91

278.69

mg/l

0.41

241

Female infertility, cervical, vaginal, other or unspecified origin

157

811

1.26

2.04

1.1

210.15

221.26

mg/l

0.36

142

705

Deep endometriosis

318

1.52

2.03

1.1

212.42

211.28

mg/l

0.01

275

Statin medication

363

1755

1.16

2.03

1.1

282.74

266.87

mg/l

0.52

325

1536

Alcohol use disorder, Swedish definition

226

1721

1.21

2.02

1.1

279.11

283.82

mg/l

0.09

197

1511

Ingrowing nail

162

1.74

2.02

1.1

317.68

262.76

mg/l

0.46

136

Iron deficiency

1.98

2.01

1.0

1.1

184.56

214.71

mg/l

—

Artrosis, including avohilmo

395

1872

1.16

2.00

1.1

241.06

282.57

mg/l

4.55

348

1637

Medicines for HER+ breast cancer

970

0.73

1.98

1.2

1.1

311.21

252.85

mg/l

0.52

848

Diseases of arteries, arterioles and capillaries (FINNGEN)

408

1.38

1.98

1.1

269.55

293.01

mg/l

0.58

359

Other disorders of patella

596

1.36

1.96

1.0

1.1

222.31

247.37

mg/l

1.21

515

Polyarthrosis

381

1.44

1.95

1.1

242.83

285.18

mg/l

1.32

333

Exposure to other and unspecified man-made environmental factors

2.59

1.95

1.1

253.30

230.79

mg/l

—

Ethmoidectomy

395

1.45

1.94

1.1

246.90

269.65

mg/l

0.44

344

FESS (DNB20)

387

1.45

1.94

1.1

248.79

270.96

mg/l

0.42

337

Preterm labour and delivery

125

980

1.28

1.93

1.1

258.15

223.71

mg/l

0.39

109

854

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

276

2283

1.18

1.91

1.1

220.67

244.16

mg/l

1.13

250

1996

Perineal laceration during delivery

793

0.73

1.91

1.0

1.1

222.41

191.94

mg/l

0.60

689

Fracture of lumbar spine and pelvis

479

1.40

1.91

1.1

251.63

275.80

mg/l

0.58

407

Maternal care for other conditions predominantly related to pregnancy

130

1007

1.27

1.90

1.1

197.88

201.62

mg/l

0.17

107

875

Other disorders of male genital organs

1.97

1.90

1.2

1.1

283.72

343.78

mg/l

1.13

Collagenous colitis

251

1.56

1.89

1.0

1.1

284.06

261.74

mg/l

0.11

217

Early lumbar disc prolapse operation

473

1.40

1.89

1.1

246.02

254.90

mg/l

0.25

415

Crohn disease (strict definition, require KELA, min 2 HDR)

212

1.61

1.88

1.0

1.1

232.45

259.81

mg/l

0.45

179

Crohn disease

466

1.40

1.86

1.0

1.1

229.84

254.68

mg/l

0.63

408

Heart failure and coronary heart disease

621

0.72

1.86

1.1

297.40

325.93

mg/l

0.56

545

Symptoms and signs involving emotional state

2.04

1.85

1.1

278.25

207.86

mg/l

0.78

Other misadventures during surgical and medical care

2.22

1.85

1.1

213.85

249.58

mg/l

0.65

Other disorders of carbohydrate metabolism

4.26

1.83

1.0

1.2

226.80

193.50

mg/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

262

1681

1.18

1.83

1.1

199.78

221.50

mg/l

2.05

232

1468

Crohn disease (strict definition, require KELA)

214

1.60

1.82

1.0

1.1

232.45

260.48

mg/l

0.47

181

Allergic rhinitis

170

1376

1.22

1.82

1.1

226.91

233.96

mg/l

0.22

149

1215

Abnormal serum enzyme levels

647

1.33

1.82

1.0

1.1

259.82

338.69

mg/l

3.25

563

Recurrent dislocation and subluxation of joint

238

1.56

1.81

1.2

1.1

328.97

263.06

mg/l

0.24

200

Other disorders of breast

418

1.42

1.81

1.1

205.06

219.24

mg/l

0.48

366

KRA_PSY_EATING, excluding more controls

309

1.49

1.81

1.1

201.33

209.90

mg/l

0.10

269

Female infertility

168

829

1.23

1.81

1.1

217.63

220.18

mg/l

0.06

152

722

Inflammatory bowel disease

149

1205

1.24

1.80

1.1

239.39

253.17

mg/l

0.50

125

1064

Invasive ventilation

176

1.65

1.79

1.1

397.05

301.10

mg/l

0.37

148

Other diseases of the digestive system

736

1.31

1.78

1.1

266.52

287.52

mg/l

0.45

648

Malignant melanoma of skin

231

1.56

1.78

1.1

341.82

272.82

mg/l

0.61

204

Fracture of foot, except ankle

116

913

1.27

1.77

1.1

255.00

244.21

mg/l

0.20

808

GI-bleeding

728

1.31

1.77

1.1

268.01

289.12

mg/l

0.44

638

Major coronary heart disease event

312

1622

1.16

1.77

1.1

261.00

302.55

mg/l

2.83

269

1426

Care involving dialysis

169

1.66

1.77

1.1

395.48

308.77

mg/l

0.86

141

Degeneration of macula and posterior pole

117

731

1.27

1.76

1.1

298.00

309.51

mg/l

0.28

104

643

242

1855

1.18

1.76

1.1

277.45

286.18

mg/l

0.18

210

1628

Viral and other specified intestinal infections

152

1194

1.23

1.73

1.1

214.48

243.15

mg/l

1.35

134

1050

Other sexually transmitted chlamydial diseases

499

1.37

1.72

1.1

195.84

215.69

mg/l

0.64

424

Diabetic retinopathy, excluding more controls

367

1.33

1.70

1.1

314.45

318.94

mg/l

0.06

316

Other inflammatory liver diseases

171

1.64

1.70

1.1

252.45

275.87

mg/l

0.31

148

Acute peritonitis

133

1.74

1.70

1.1

736.59

279.82

mg/l

0.60

119

Phlebitis and thrombophlebitis (not including DVT)

612

1.33

1.69

1.1

248.71

267.10

mg/l

0.46

537

Amputation of foot

0.00

1.68

0.0

1.1

—

276.90

—

Female genital prolapse

123

550

1.27

1.68

1.1

216.30

254.45

mg/l

1.53

103

482

Alcohol use disorder, ICD-based

165

1361

1.21

1.67

1.1

280.39

289.09

mg/l

0.13

145

1209

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

239

1.53

1.66

1.1

213.37

234.52

mg/l

0.31

208

Disorders of continuity of bone

284

1.48

1.66

1.0

1.1

217.31

271.15

mg/l

1.96

249

Injury of muscle and tendon at hip and thigh level

276

1.49

1.66

1.1

303.46

288.67

mg/l

0.16

238

Mental and behavioural disorders due to alcohol, excluding acute intoxication

178

1474

1.20

1.65

1.1

282.70

289.21

mg/l

0.10

158

1308

Dislocation, sprain and strain of joints and ligaments of thorax

1.94

1.65

1.3

1.1

459.19

253.15

mg/l

0.51

Localized swelling, mass and lump of skin and subcutaneous tissue

108

852

1.27

1.64

1.1

352.56

267.23

mg/l

0.79

746

256

1935

1.17

1.63

1.1

273.51

282.97

mg/l

0.21

223

1700

Colonic or urogenital fistula

108

853

1.27

1.63

1.1

279.31

264.92

mg/l

0.33

744

Medical abortion

308

1447

1.16

1.63

1.1

216.69

222.95

mg/l

0.32

270

1261

Other congenital malformations of brain

3.64

1.62

1.0

301.80

337.43

mg/l

—

Mental disorders, not otherwise specified

319

1.45

1.62

1.0

1.1

206.44

238.57

mg/l

1.10

276

Cellulitis

696

1.30

1.61

1.1

358.84

265.60

mg/l

1.13

609

Glucosamine medication

122

779

1.25

1.61

1.1

299.18

305.97

mg/l

0.08

108

689

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

409

2319

1.13

1.60

1.1

275.14

272.51

mg/l

0.05

363

2037

Infectious mononucleosis

395

1.40

1.60

1.1

261.33

229.99

mg/l

0.26

337

Respiratory disorders in diseases classified elsewhere

2.52

1.60

1.1

338.50

238.81

mg/l

—

Other diseases of blood and blood-forming organs

151

1.66

1.60

1.1

274.26

287.84

mg/l

0.14

128

Melanocytic naevi, other sites/unspecified

238

1.52

1.59

1.1

220.62

255.93

mg/l

0.79

205

Bacterial, viral and other infectious agents

296

1.46

1.57

1.1

255.25

274.49

mg/l

0.32

256

Mixed conductive and sensorineural hearing loss

255

1.49

1.57

1.1

259.97

286.65

mg/l

0.55

224

Nonsuppurative otitis media

129

903

1.24

1.57

1.1

244.83

244.12

mg/l

0.01

115

789

Vulvovaginal ulceration/inflammation in other diseases

223

1.53

1.57

1.1

274.83

202.12

mg/l

1.04

192

Vasomotor rhinitis (mode)

199

1.56

1.1

220.75

280.62

mg/l

1.12

173

Acute renal failure

439

1.37

1.56

1.2

1.1

363.18

312.39

mg/l

0.34

378

Other (seronegative) rheumatoid arthritis, wide

465

1.36

1.56

1.0

1.1

259.45

266.52

mg/l

0.12

406

Atopic dermatitis, strict definition

167

1362

1.20

1.56

1.1

208.91

227.56

mg/l

0.83

148

1201

Allergic conjunctivitis

286

2425

1.15

1.55

1.1

220.66

246.43

mg/l

1.36

258

2125

Endometriosis ASRM stages 1,2

709

1.29

1.55

1.1

204.05

212.06

mg/l

0.32

633

Obesity, other/unspecified

168

1401

1.20

1.55

1.1

227.39

241.66

mg/l

0.72

154

1225

Diabetic retinopathy

101

493

1.28

1.54

1.1

310.37

315.32

mg/l

0.08

427

Substance use, excluding alcohol

745

1.28

1.54

1.1

274.77

259.06

mg/l

0.19

665

Injuries to the hip and thigh

160

1202

1.21

1.54

1.1

263.46

275.49

mg/l

0.25

138

1070

Other congenital malformations

323

1.43

1.52

1.1

182.74

226.80

mg/l

2.19

278

Toxic effects of substances chiefly nonmedicinal as to source

382

1.39

1.52

1.1

204.82

261.32

mg/l

3.02

332

Gastroduodenal ulcer

500

1.34

1.52

1.1

285.00

311.91

mg/l

0.50

445

Other disorders starting during childhood or adolescence

223

1.52

1.51

1.1

189.45

222.36

mg/l

0.61

193

Necrosis of pulp, including avohilmo

277

2406

1.15

1.50

1.1

240.69

259.11

mg/l

0.69

235

2115

Disorders of parathyroid gland

420

1.37

1.50

1.1

289.76

269.07

mg/l

0.15

365

Atopic dermatitis, strict definition with reimbursement

166

1340

1.20

1.49

1.1

210.58

226.85

mg/l

0.68

147

1176

Viral warts

333

1.42

1.49

1.0

1.1

240.76

255.61

mg/l

0.23

291

Type 2 diabetes, wide definition

304

1700

1.15

1.49

1.1

306.71

283.42

mg/l

0.69

259

1505

Other respiratory diseases principally affecting the interstitium

333

1.41

1.49

1.1

267.78

294.19

mg/l

0.58

286

Rheumatoid arthritis, including avohilmo

134

1098

1.22

1.49

1.1

275.52

261.70

mg/l

0.22

119

958

Cholecystectomy

278

2088

1.15

1.49

1.1

275.12

266.21

mg/l

0.25

248

1825

Extracorporeal dialysis

139

1.66

1.48

1.1

1.0

435.35

287.14

mg/l

1.56

124

Excessive vomiting in pregnancy

351

1.40

1.47

1.1

187.25

210.95

mg/l

0.87

301

Schizophrenia

582

0.70

1.47

1.0

1.1

243.94

266.25

mg/l

0.52

513

conjunctival degenerations and deposits

2.24

1.47

1.0

1.1

216.20

230.58

mg/l

—

Atrial fibrillation and flutter

107

552

1.26

1.46

1.1

270.33

279.92

mg/l

0.26

483

Complications predominantly related to the puerperium

136

1119

1.22

1.46

1.1

192.45

210.69

mg/l

1.47

117

985

Recurrent dislocation of patella

219

1.51

1.46

1.1

201.73

219.75

mg/l

0.51

185

Viral pneumonia

360

1.39

1.45

1.1

282.20

277.21

mg/l

0.06

310

Amenorrhoea

310

1.43

1.45

1.1

224.32

200.94

mg/l

0.38

274

Follicular cysts of skin and subcutaneous tissue

567

1.31

1.45

1.1

250.84

265.40

mg/l

0.31

494

Benign neoplasm: Anus and anal canal

2.13

1.44

1.2

1.1

276.91

244.96

mg/l

0.25

Disorder of lipoprotein metabolism, unspecified

244

1.48

1.44

1.1

320.10

304.65

mg/l

0.17

209

L04AD Calcineurin inhibitors

344

1.40

1.44

1.1

308.97

281.00

mg/l

0.33

297

Gout

437

1.33

1.44

1.0

1.1

446.15

352.33

mg/l

0.81

380

Benign neoplasm: Long bones of lower limb

1.80

1.43

1.0

1.1

225.82

257.30

mg/l

0.56

Viral and other specified intestinal infections

114

901

1.24

1.43

1.1

216.72

240.33

mg/l

1.00

102

789

Gastric ulcer

336

1.40

1.43

1.1

294.94

310.54

mg/l

0.18

293

Mental and behavioural disorders due to alcohol

211

1739

1.17

1.42

1.1

275.32

282.88

mg/l

0.14

187

1531

Other puerperal infections

389

1.37

1.39

1.0

1.1

190.55

196.67

mg/l

0.22

341

Mental and behavioural disorders due to opioids

134

1.65

1.39

1.0

1.1

222.71

252.04

mg/l

0.60

111

Other disorders of veins

150

1246

1.20

1.38

1.1

321.24

262.49

mg/l

0.58

132

1094

Noninflammatory disorders of female genital tract

220

946

1.17

1.38

1.1

207.16

221.21

mg/l

0.56

192

826

Diabetic retinopathy, strict definition

366

1.35

1.37

1.0

1.1

297.51

293.05

mg/l

0.05

319

Acute lymphocytic leukaemia, including Hilmo

2.64

1.37

1.0

166.50

187.61

mg/l

—

Acute lymphocytic leukaemia, helper endpoint

2.64

1.37

1.0

166.50

187.61

mg/l

—

Acute lymphocytic leukaemia

2.64

1.37

1.0

166.50

187.61

mg/l

—

Other disorders of the musculoskeletal system and connective tissue

373

1.37

1.2

1.1

275.82

277.68

mg/l

0.03

320

Malignant neoplasm of breast, HER-positive

698

0.77

1.36

1.2

1.1

323.45

243.71

mg/l

0.71

610

Coronary revascularization (ANGIO or CABG)

287

1540

1.14

1.36

1.1

265.77

303.71

mg/l

2.19

246

1355

Percutaneous Coronary Intervention

286

1538

1.14

1.34

1.1

265.77

303.56

mg/l

2.17

245

1353

Primary gonarthrosis, bilateral

142

1013

1.20

1.34

1.0

1.1

274.42

311.69

mg/l

1.28

125

888

Trigger finger

316

1.39

1.32

1.1

315.82

265.70

mg/l

0.62

271

Deep bite

351

1.35

1.32

1.1

194.87

253.64

mg/l

2.07

302

Infections of genitourinary tract in pregnancy

376

1.36

1.32

1.1

192.87

213.97

mg/l

1.02

328

Erysipelas

262

1751

1.14

1.32

1.1

379.25

269.47

mg/l

2.13

228

1554

Left ventricular outflow tract obstruction, narrow definition

148

0.47

1.32

1.1

316.43

295.17

mg/l

—

127

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

233

1.46

1.31

1.0

1.1

232.45

260.60

mg/l

0.47

199

Use of other anti-dementia drugs

254

1.40

1.31

1.1

294.41

331.61

mg/l

0.67

223

Use of memantine

254

1.40

1.31

1.1

294.41

331.61

mg/l

0.67

223

Other hammer toe(s) (acquired)

315

1.38

1.31

1.0

1.1

309.05

285.43

mg/l

0.26

275

Retinal breaks without detachment

377

1.36

1.30

1.1

268.38

282.55

mg/l

0.18

335

Mental retardation, excluding more controls

1.81

1.29

1.2

1.1

198.38

258.52

mg/l

0.93

Myocardial infarction, strict

815

0.80

1.29

1.1

339.54

337.60

mg/l

0.02

723

Other gastritis (incl. Duodenitis)

525

1.30

1.29

1.1

273.81

294.01

mg/l

0.38

464

Suppurative and unspecified otitis media

203

1553

1.16

1.28

1.1

232.47

239.84

mg/l

0.20

182

1365

Hypocalcemia

2.10

1.28

1.6

1.1

169.30

234.98

mg/l

—

Endometriosis ASRM stages 3,4

102

829

1.23

1.27

1.0

1.1

232.58

216.98

mg/l

0.33

737

Other abnormal products of conception

188

1066

1.17

1.26

1.1

187.75

203.68

mg/l

1.50

166

932

Primary open-angle glaucoma, strict

447

1.32

1.26

1.1

307.55

297.41

mg/l

0.12

393

Scabies

580

1.28

1.26

1.1

283.82

239.61

mg/l

0.92

509

Early onset COPD

536

1.29

1.26

1.2

1.1

390.34

297.52

mg/l

0.38

465

Ischaemic heart disease, wide definition

262

1424

1.14

1.25

1.1

274.53

306.68

mg/l

1.40

219

1249

Prolonged pregnancy

732

0.77

1.25

1.1

186.71

206.87

mg/l

0.73

641

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

135

1131

1.20

1.25

1.1

245.16

245.54

mg/l

0.01

118

1006

Unspecified acute lower respiratory infection

476

1.31

1.24

1.2

1.1

269.98

273.32

mg/l

0.04

414

Seborrhoeic dermatitis

237

1.44

1.22

1.3

1.1

324.66

285.26

mg/l

0.32

201

Diseases of peritoneum

237

1.44

1.22

1.1

1.0

520.30

277.52

mg/l

0.48

206

L02BG Aromatase inhibitors

753

0.77

1.22

1.1

341.75

258.17

mg/l

0.60

658

Seropositive rheumatoid arthritis

607

1.27

1.22

1.1

309.60

268.90

mg/l

0.45

527

Renal failure

123

904

1.20

1.22

1.1

330.25

303.45

mg/l

0.33

101

791

Contact with sharp glass

124

1.62

1.21

1.1

198.43

259.84

mg/l

1.18

103

Heart failure and bmi 25plus

495

0.76

1.20

1.1

300.98

332.12

mg/l

0.51

432

Ankylosing spondylitis, ICD10

280

1.40

1.20

1.1

300.32

282.35

mg/l

0.09

237

Malignant neoplasm of breast, ER-positive, including Hilmo

711

0.79

1.20

1.2

1.1

314.83

243.15

mg/l

0.66

620

ILD, hospital admissions

280

1.40

1.20

1.1

286.29

295.11

mg/l

0.14

240

Other and unspecified disorders of psychological development

2.14

1.19

1.0

1.1

127.25

244.66

mg/l

—

Acute laryngitis and tracheitis

515

1.28

1.18

1.1

197.05

241.39

mg/l

2.07

453

Chronic pancreatitis

298

1.38

1.18

1.1

327.69

317.98

mg/l

0.05

250

Other interstitial pulmonary diseases

281

1.39

1.18

1.1

286.29

298.38

mg/l

0.20

241

Stomatitis and related lesions

676

1.24

1.17

1.1

253.17

247.94

mg/l

0.10

592

Malignant neoplasm of bronchus and lung, including Hilmo

299

1.34

1.16

1.0

1.1

353.40

300.25

mg/l

0.70

269

Other follicular disorders

265

1.40

1.16

1.2

1.1

262.29

262.05

mg/l

0.00

224

Interstitial lung disease

282

1.39

1.16

1.1

286.29

297.91

mg/l

0.19

242

Interstitial lung disease endpoints

282

1.39

1.16

1.1

286.29

297.91

mg/l

0.19

242

Early syphilis

2.07

1.15

1.1

279.50

253.44

mg/l

—

Gout, FINNGEN

516

1.28

1.14

1.0

1.1

446.15

326.99

mg/l

1.17

446

Other congenital malformations

491

1.29

1.14

1.1

195.72

236.32

mg/l

2.00

433

Intestinal stricture

741

1.23

1.14

1.1

272.14

287.96

mg/l

0.35

649

Cholecystitis

300

1.37

1.14

1.1

305.15

288.58

mg/l

0.08

257

Dysplasia of cervi uteri

127

772

1.19

1.13

1.1

195.35

221.81

mg/l

1.37

108

676

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.35

1.12

1.1

1193.00

249.21

mg/l

—

Biological medication for rheuma

680

1.24

1.12

1.1

214.54

248.50

mg/l

1.27

610

Other and unspecified psoriasis

159

1.51

1.12

1.1

299.88

291.52

mg/l

0.03

133

Procedures for purposes other than remedying health state

1.97

1.11

1.0

1.1

256.40

240.44

mg/l

—

Other fall from one level to another

798

1.22

1.11

1.1

253.97

256.90

mg/l

0.06

700

Crohn's disease NAS

226

1.42

1.10

1.0

1.1

244.45

261.73

mg/l

0.22

195

Erysipelas

180

1382

1.15

1.10

1.1

399.86

280.27

mg/l

1.46

154

1225

Emergency coronary revascularization (for ACS)

299

1625

1.12

1.10

1.1

270.40

303.27

mg/l

1.79

257

1428

Allergic contact dermatitis

442

1.29

1.09

1.0

1.1

276.15

242.40

mg/l

0.37

387

Other specific arthropathies, wide

1.96

1.09

1.0

1.1

199.13

225.39

mg/l

—

Superficial injury of forearm

346

1.33

1.09

1.1

251.06

246.75

mg/l

0.05

298

Cyst of kidney

136

1.55

1.08

1.1

377.38

312.56

mg/l

0.46

119

Malignant neoplasm, wide definition for exclusion

396

2109

1.10

1.08

1.1

312.40

255.91

mg/l

1.27

345

1855

Polycystic ovarian syndrome, broad definition

576

1.25

1.08

1.0

1.1

197.45

199.39

mg/l

0.05

508

Corneal ulcer

639

1.24

1.07

1.1

250.79

260.83

mg/l

0.20

562

Early syphilis

2.14

1.06

1.1

283.43

262.19

mg/l

—

Injury of eye and orbit

515

1.26

1.06

1.1

255.64

267.54

mg/l

0.25

456

Sequelae of other external causes

145

1.52

1.06

1.0

1.1

281.47

263.21

mg/l

0.09

122

Torsion of ovary, ovarian pedicle and fallopian tube

1.72

1.05

1.1

1.0

214.36

213.60

mg/l

0.01

Injury of muscle and tendon at wrist and hand level

418

1.29

1.05

1.2

1.1

337.91

275.48

mg/l

0.50

373

Congenital malformations of aortic and mitral valves

122

0.49

1.05

1.2

1.1

356.50

288.84

mg/l

—

107

Glomerular disorders in diseases classified elsewhere

288

1.36

1.04

1.1

290.83

288.80

mg/l

0.02

244

Seminoma of testis

2.29

1.04

1.0

1.1

257.60

297.65

mg/l

—

IBD patients in KELA-register

109

915

1.19

1.03

1.0

1.1

224.30

253.84

mg/l

1.58

816

Papulosquamous disorders

145

1247

1.16

1.03

1.1

260.01

265.79

mg/l

0.11

124

1101

Hereditary retinal dystrophy

2.07

1.03

1.0

1.1

227.71

209.34

mg/l

—

Malignant neoplasm of cervix uteri

2.07

1.03

1.0

203.86

207.00

mg/l

—

Fracture of skull and facial bones

724

1.22

1.03

1.1

359.06

265.29

mg/l

0.56

644

Loose body in joint

1.92

1.02

1.1

343.56

305.68

mg/l

—

Sulfasalazine

108

908

1.19

1.01

1.0

1.1

291.29

260.53

mg/l

0.48

802

Ulcerative colitis

106

891

1.19

1.00

1.1

244.32

257.61

mg/l

0.40

793

Ulcer of oesophagus

123

1.55

0.99

1.1

1.0

249.89

315.42

mg/l

1.36

108

Acne

484

1.26

0.99

1.2

1.1

277.76

214.92

mg/l

0.60

413

Other condition

467

1.27

0.98

1.1

230.85

260.15

mg/l

1.06

404

Other maternal disorders predominantly related to pregnancy

283

1595

1.11

0.98

1.1

212.12

224.41

mg/l

0.62

253

1382

All-cause Heart Failure

113

941

0.85

0.98

1.1

274.00

316.97

mg/l

1.65

827

Primary open-angle glaucoma

529

1.24

0.98

1.1

322.80

305.87

mg/l

0.21

462

Open wound of lower leg

441

1.27

0.97

1.1

261.00

265.42

mg/l

0.06

378

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.81

0.97

1.0

1.1

197.11

202.98

mg/l

—

Blepharochalasis

612

1.23

0.96

1.1

289.67

282.96

mg/l

0.08

531

685

1.21

0.96

1.1

300.25

311.66

mg/l

0.12

604

Other complications of labour and delivery, not elsewhere classified

626

0.79

0.96

1.1

173.66

189.75

mg/l

0.82

544

Disorders of gallbladder, biliary tract and pancreas

412

2382

1.09

0.96

1.1

265.74

273.92

mg/l

0.30

362

2089

Personal history of other diseases and conditions

476

1.26

0.95

1.1

217.46

217.07

mg/l

0.01

423

Other benign neoplasms of skin

121

1034

1.17

0.95

1.0

1.1

284.33

266.62

mg/l

0.29

110

906

Use of disulfiram, acamprosate or naltrexone

276

1.34

0.95

1.1

258.58

303.12

mg/l

0.96

237

Pregnancy with abortive outcome

309

1458

1.11

0.94

1.1

219.75

222.72

mg/l

0.11

271

1269

Abnormal findings in nipple discharge synovial fluid wound secretions

1.90

0.94

1.1

1.0

189.00

241.41

mg/l

—

Skin changes due to chronic exposure to nonionizing radiation

624

1.21

0.94

1.0

1.1

312.44

311.51

mg/l

0.01

550

Periapical abscess

185

1633

1.13

0.94

1.1

248.51

273.42

mg/l

1.23

160

1448

Paralytic ileus and intestinal obstruction

596

1.23

0.93

1.1

263.90

299.79

mg/l

1.12

513

Colorectal cancer

400

0.73

0.93

1.1

335.56

296.24

mg/l

0.33

361

Generalized epilepsy, strict definition

1.72

0.93

1.0

1.1

181.50

237.29

mg/l

0.74

Malignant neoplasm of respiratory system and intrathoracic organs

288

1.30

0.92

1.0

400.00

302.51

mg/l

1.30

257

Alcoholic liver disease

226

1.37

0.92

1.1

276.08

312.55

mg/l

0.77

198

Acne vulgaris

383

1.28

0.92

1.1

289.72

221.25

mg/l

0.50

325

Heart failure, strict

116

956

0.86

0.91

1.1

273.21

324.08

mg/l

1.98

840

5-aminosalicylic acid

744

1.20

0.91

1.0

1.1

264.45

256.43

mg/l

0.08

668

Familial hypercholesterolemia

261

1.34

0.91

1.1

345.57

302.29

mg/l

0.55

230

Angina pectoris

168

982

1.14

0.90

1.1

285.81

327.80

mg/l

1.61

143

868

Acute suppurative otitis media

151

1231

1.15

0.90

1.1

232.06

240.61

mg/l

0.20

134

1087

Myocardial infarction, unclassifiable

301

0.71

0.89

1.0

1.1

367.59

329.31

mg/l

0.35

259

Hypertrophy of breast in women and men

682

1.20

0.89

1.2

1.1

283.67

236.50

mg/l

0.39

597

Periodontitis

402

2474

1.09

0.89

1.1

275.24

274.29

mg/l

0.03

360

2164

Amiodarone users

194

0.62

0.88

1.0

1.1

352.50

311.92

mg/l

0.33

166

Other disorders of kidney and ureter

306

1.31

0.88

1.1

526.91

298.93

mg/l

0.55

262

Kela-code for severe mental illness

161

1416

1.14

0.88

1.0

1.1

233.61

259.77

mg/l

1.20

138

1256

Nasal polyp

502

1.24

0.88

1.0

1.1

271.87

285.40

mg/l

0.21

438

Inflammatory bowel disease, strict (require KELA)

109

932

1.17

0.87

1.0

1.1

224.30

252.56

mg/l

1.48

829

Bicipital tendinitis

1.58

0.87

1.1

298.20

292.11

mg/l

0.04

Postmenopausal osteoporosis with pathological fracture

1.58

0.87

1.1

1.0

314.11

267.27

mg/l

—

Open wound of ankle and foot

316

1.30

0.86

1.1

196.75

251.26

mg/l

2.74

270

Other and unspecified intracranial injuries

1.73

0.86

1.0

226.27

240.00

mg/l

0.14

Chronic periodontitis, including avohilmo

400

2471

1.09

0.86

1.1

275.51

274.38

mg/l

0.04

358

2161

Schizophrenia or delusion

142

1241

1.15

0.86

1.0

1.1

220.49

262.52

mg/l

2.55

120

1098

Injuries to the elbow and forearm

301

2414

1.10

0.85

1.1

259.17

268.40

mg/l

0.26

251

2144

Antenatal screening

654

0.85

1.1

243.87

210.05

mg/l

0.37

553

Persons encountering health services in circumstances related to reproduction

277

1693

1.10

0.85

1.1

249.32

271.43

mg/l

0.92

253

1468

Peripheral arterial reconstruction

263

0.68

0.85

1.1

395.69

320.50

mg/l

0.42

228

Pregnancy, childbirth and the puerperium

586

0.85

0.84

1.1

195.08

215.21

mg/l

0.95

508

Nontoxic goitre/thyroid nodule

790

0.82

0.84

1.1

270.78

252.78

mg/l

0.25

687

Hypertrophy of breast

605

1.21

0.84

1.2

1.1

266.86

223.05

mg/l

0.31

531

Gestational diabetes (for exclusion)

219

1367

1.12

0.84

1.1

202.53

201.10

mg/l

0.05

201

1196

Endometriosis of ovary

608

1.21

0.84

1.0

1.1

230.14

220.03

mg/l

0.17

537

Delivery

138

835

0.87

0.84

1.1

222.63

228.68

mg/l

0.16

119

723

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

366

0.74

0.83

1.0

1.1

360.73

291.35

mg/l

0.51

331

Dermatophytosis

251

2273

1.10

0.83

1.1

260.34

271.28

mg/l

0.39

224

1999

Certain conditions originating in the perinatal period

329

1.27

0.83

1.1

230.69

204.41

mg/l

0.18

284

Galactorrhea

1.89

0.82

1.3

1.1

150.83

191.72

mg/l

—

Schizophrenia, schizotypal and delusional disorders

142

1247

1.14

0.81

1.0

1.1

220.49

262.74

mg/l

2.59

120

1104

Infective dermatitis

284

1.31

0.81

1.1

245.29

277.13

mg/l

0.74

244

Alcohol dependence

791

1.18

0.81

1.1

259.60

302.11

mg/l

1.57

706

Later onset COPD

318

0.75

0.81

1.0

1.1

309.92

325.57

mg/l

0.18

275

Malignant neoplasm of breast, ER-negative, including Hilmo

486

0.78

0.80

1.2

1.1

234.94

246.17

mg/l

0.25

428

Ulcerative colitis, NAS

472

1.23

0.80

1.1

230.26

262.50

mg/l

1.11

418

Malignant neoplasm of bronchus and lung

250

1.30

0.80

1.0

1.1

373.62

306.10

mg/l

0.76

225

Single delivery by caesarean section

565

0.84

0.80

1.1

201.49

204.62

mg/l

0.08

495

Sulfonylureas

486

0.80

1.0

1.1

343.15

311.08

mg/l

0.54

428

Heart failure and antihypertensive medication

396

1.21

0.80

1.2

1.1

242.22

310.51

mg/l

1.82

350

Gonarthrosis,primary

294

1654

1.10

0.79

1.1

281.07

303.53

mg/l

0.97

258

1447

Family history of malignant neoplasm

383

1.26

0.79

1.0

1.1

302.83

230.20

mg/l

0.61

342

Oligomenorrhoea

139

1.44

0.79

1.2

1.0

233.35

212.79

mg/l

0.51

121

Diabetes, insulin treatment (Kela reimbursement)

372

2431

0.92

0.79

1.1

314.36

272.74

mg/l

1.75

329

2134

Burns and corrosions

474

1.23

0.78

1.1

226.90

262.77

mg/l

1.39

413

Idiopathic pulmonary fibrosis

123

0.57

0.77

1.3

1.0

215.86

284.77

mg/l

—

103

Gestational [pregnancy-induced] hypertension

136

1194

1.14

0.77

1.1

194.39

207.39

mg/l

0.65

126

1039

Other diseases of intestine

322

1.27

0.77

1.0

1.1

291.91

303.56

mg/l

0.11

273

Peripheral artery disease

675

0.84

0.77

1.1

425.53

320.75

mg/l

0.45

595

Pleural effusion

278

1.30

0.77

1.1

267.66

306.17

mg/l

0.71

236

Pollen allergy

102

869

1.16

0.76

1.1

208.13

224.43

mg/l

0.79

765

Disorders of tooth development and eruption

517

1.19

0.76

1.1

369.02

261.27

mg/l

0.32

461

Mental and behavioural disorders due to tobacco

244

1.31

0.75

1.1

283.19

283.38

mg/l

0.00

213

Insulin, combination of fast acting with intermediate-acting or long-acting

219

1813

1.10

0.75

1.1

325.65

277.85

mg/l

1.58

187

1608

Other bursal cyst

2.09

0.74

1.0

1.1

226.60

283.16

mg/l

—

Suggestive for eosinophilic asthma

227

1.32

0.74

1.0

1.1

253.21

298.07

mg/l

0.59

195

Ulcerative rectosigmoiditis

271

1.29

0.74

1.0

1.1

242.07

281.77

mg/l

1.15

233

Acute alcohol intoxication

799

1.17

0.74

1.2

1.1

235.15

278.77

mg/l

2.69

710

Malignant neoplasm of skin

133

801

1.14

0.74

1.1

381.43

281.95

mg/l

0.89

111

710

Mandibular retrognathia

244

1.31

0.74

1.1

210.78

236.16

mg/l

0.47

217

Open bite that required surgery (Lefort1 or BSSO)

1.86

0.74

1.0

1.1

206.43

230.41

mg/l

—

Aortic aneurysm

428

0.78

0.73

1.0

1.1

278.16

324.64

mg/l

0.85

373

Dislocation, sprain and strain of joints and ligaments of head

133

1.43

0.73

1.0

1.1

219.93

254.35

mg/l

0.47

109

Cholelithiasis, broad definition with cholecystitis

344

2140

1.08

0.73

1.1

267.08

273.97

mg/l

0.21

299

1879

Type 1 diabetes

113

985

1.15

0.73

1.1

300.80

251.73

mg/l

1.12

879

Mucosal proctocolitis

451

1.22

0.73

1.1

229.74

268.33

mg/l

1.32

397

Macular pucker

263

1.29

0.72

1.1

303.77

289.82

mg/l

0.14

235

Any event in cancer register

424

2327

1.07

0.72

1.1

328.60

249.68

mg/l

1.77

367

2046

Foreign body or object entering through skin

211

1.33

0.72

1.1

268.18

291.39

mg/l

0.37

179

Other salmonella infections

1.55

0.72

1.1

1.0

232.08

248.85

mg/l

0.28

Smoking dependency

246

1.30

0.72

1.1

283.19

282.51

mg/l

0.01

214

Hallux valgus (acquired)

109

682

1.15

0.71

1.1

298.47

262.64

mg/l

0.36

593

Unstable angina pectoris

602

1.17

0.71

1.1

318.69

326.57

mg/l

0.13

533

COPD-related respiratory insufficiency

194

1.34

0.71

1.0

1.1

639.38

320.96

mg/l

0.49

165

Benign leiomyoma with endometriosis

382

1.23

0.69

1.1

279.64

234.65

mg/l

0.74

341

Seminoma of testis, including Hilmo

1.86

0.68

1.0

1.1

257.60

280.32

mg/l

—

Corneal scars and opacities

1.53

0.68

1.1

1.0

220.44

244.69

mg/l

—

Polycythaemia vera

1.53

0.68

1.0

1.1

275.33

241.42

mg/l

—

Salpingitis and oophoritis

510

1.20

0.68

1.1

209.30

228.12

mg/l

0.61

444

Other and unspecified injuries of head

161

1.37

0.68

1.2

1.1

274.06

290.16

mg/l

0.14

135

Contraceptive management

205

1305

1.10

0.68

1.1

235.25

262.63

mg/l

1.29

181

1134

Malignant neoplasm of testis

1.63

0.67

1.0

1.1

272.86

283.74

mg/l

—

Arterial embolism and thrombosis

0.55

0.67

1.0

1.1

192.20

261.82

mg/l

—

Parapsoriasis

1.63

0.67

1.0

1.1

158.14

234.32

mg/l

—

Puerperal sepsis

375

1.23

0.66

1.0

1.1

209.27

235.13

mg/l

0.75

334

Other specified and unspecified disorders of eye and adnexa

1.52

0.66

1.1

261.38

228.20

mg/l

0.40

Psoriatic and enteropathic arthropathies

321

1.25

0.66

1.0

1.1

240.59

270.22

mg/l

0.58

275

Single spontaneous delivery

140

832

0.89

0.66

1.1

219.17

228.93

mg/l

0.29

121

720

Scoliosis

241

1.29

0.65

1.1

1.0

230.00

237.61

mg/l

0.07

207

Actinic keratosis

602

1.17

0.65

1.0

1.1

321.06

314.11

mg/l

0.06

530

Burn and corrosion confined to eye and adnexa

1.58

0.65

1.0

1.1

238.09

263.39

mg/l

0.29

Peritonsillar abscess

800

1.15

0.65

1.1

229.04

240.13

mg/l

0.38

701

Atherosclerosis, excluding cerebral and coronary sclerosis

599

0.85

0.65

1.1

309.36

324.18

mg/l

0.21

529

Postprocedural musculoskeletal disorders, not elsewhere classified

154

1.37

0.65

1.1

1.0

253.27

299.48

mg/l

0.64

132

Olecranon bursitis

103

1.46

0.65

1.1

261.47

320.84

mg/l

1.09

Insulin, fast-acting

135

1204

1.12

0.65

1.1

293.73

261.38

mg/l

0.80

114

1071

Artificial joint operation, meniscal resection

330

1990

1.08

0.64

1.1

277.67

293.07

mg/l

0.48

290

1748

Malignant neoplasm

363

2002

1.07

0.64

1.1

347.43

258.10

mg/l

1.71

315

1765

Acute pancreatitis

515

1.19

0.63

1.1

251.75

292.89

mg/l

0.99

443

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

333

1.23

0.62

1.0

1.1

189.59

213.53

mg/l

0.97

294

Benign neoplasm: Liver

1.59

0.62

1.0

1.1

174.80

222.88

mg/l

—

LSIL lesion of the cervix uteri, vagina or vulva

590

1.17

0.62

1.0

1.1

199.49

209.54

mg/l

0.38

521

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

219

1747

1.09

0.61

1.1

203.06

222.32

mg/l

1.56

204

1519

Redundant prepuce, phimosis and paraphimosis

621

1.16

0.61

1.2

1.1

339.75

331.58

mg/l

0.08

554

Delivery, wide proxy

116

695

0.89

0.61

1.1

210.84

223.48

mg/l

0.43

599

Adalimumab

352

1.22

0.61

1.1

229.12

260.41

mg/l

0.53

305

Other congenital malformations of male genital organs

0.00

0.60

0.0

1.1

—

248.31

—

Myocardial infarction

109

865

0.89

0.60

1.1

322.64

334.10

mg/l

0.16

764

Complications following abortion and ectopic and molar pregnancy

1.50

0.60

1.1

1.0

243.33

239.00

mg/l

0.03

Acute alcohol intoxication, ICD10

695

1.15

0.59

1.2

1.1

230.51

270.93

mg/l

2.27

613

Excessive earwax

181

1612

1.10

0.58

1.1

315.05

276.56

mg/l

0.41

154

1421

Erythema intertrigo

1.51

0.58

1.5

1.0

306.63

276.56

mg/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

228

1231

1.09

0.58

1.1

190.15

226.87

mg/l

4.07

201

1067

Cholelithiasis

327

2105

1.07

0.58

1.1

268.50

271.80

mg/l

0.09

286

1845

Thyrotoxicosis with diffuse goitre

455

1.19

0.58

1.1

257.20

236.04

mg/l

0.32

400

Benign neoplasm: Short bones of upper limb

1.72

0.58

1.0

1.1

155.17

223.37

mg/l

—

Diabetic nephropathy

323

1.22

0.57

1.1

315.45

317.80

mg/l

0.02

280

Thoracic aortic aneurysm

309

0.78

0.57

1.0

1.1

287.00

333.98

mg/l

0.58

270

Alcohol-induced chronic pancreatitis

158

1.33

0.57

1.0

1.1

257.62

322.43

mg/l

1.13

138

Pediculosis, acariasis and other infestations

661

1.15

0.56

1.1

280.26

248.90

mg/l

0.59

583

Diabetic maculopathy

284

1.23

0.55

1.0

1.1

314.34

280.41

mg/l

0.43

245

Bitten or struck by other mammals

421

1.19

0.55

1.1

209.20

247.70

mg/l

2.09

367

Ulcer of lower limb, not elsewhere classified

275

1.24

0.55

1.1

541.20

320.22

mg/l

0.39

235

Motorcycle rider injured in other and unspecified transport accidents

204

1.28

0.54

1.0

1.1

254.81

285.28

mg/l

0.52

173

Superficial injury of neck

1.48

0.54

1.2

1.1

194.78

219.02

mg/l

—

Melanocytic naevi of scalp and neck

1.48

0.53

1.0

1.1

312.33

220.04

mg/l

—

Insulin, fast-acting or short human

135

1222

1.10

0.53

1.1

293.73

263.46

mg/l

0.72

114

1082

Congenital malformations of breast

1.46

0.53

1.1

201.56

202.35

mg/l

—

Other congenital malformations of peripheral vascular system

1.54

0.53

1.0

1.1

339.17

203.21

mg/l

—

Alcohol abuse counselling and surveillance

1.54

0.53

1.0

1.1

298.33

266.81

mg/l

—

Maternal care for known or suspected malpresentation of fetus

744

0.88

0.53

1.1

193.14

208.71

mg/l

0.88

652

Diabetic nephropathy, excluding more controls

272

1.21

0.52

1.1

315.45

318.42

mg/l

0.03

235

Bicuspidal aortic valve syndrome

0.61

0.52

1.2

1.1

356.50

292.15

mg/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.50

0.51

1.5

1.1

448.33

219.34

mg/l

—

Conduction disorders

601

1.13

0.51

1.1

307.93

294.95

mg/l

0.14

524

Pregnancy hypertension

201

1665

1.08

0.51

1.1

201.91

215.40

mg/l

0.93

187

1449

Other endocrine disorders

163

1.30

0.51

1.1

177.62

217.80

mg/l

0.75

141

Diabetic maculopathy, excluding more controls

315

1.21

0.50

1.0

1.1

314.34

276.13

mg/l

0.49

268

Acute pancreatitis (for exclusion)

528

1.16

0.50

1.1

251.75

285.49

mg/l

0.75

451

Erosion and ectropion of cervix uteri

1.50

0.49

1.0

247.30

228.26

mg/l

—

Sub-endpoint used in defining T1D endpoints

115

1021

1.11

0.49

1.1

299.07

256.02

mg/l

0.93

904

Other/unspecified seropositive rheumatoid arthritis

669

1.14

0.49

1.1

311.43

264.24

mg/l

0.54

595

Other and unspecified injuries of lower leg

252

1.23

0.49

1.0

1.1

248.99

251.41

mg/l

0.02

214

1.44

0.49

1.1

161.86

203.38

mg/l

—

Coxarthrosis [arthrosis of hip](FG)

148

951

1.10

0.49

1.1

302.88

299.21

mg/l

0.08

126

828

Other disorders of prostate

1.56

0.49

1.0

296.71

335.42

mg/l

—

Effects of foreign body entering through natural orifice

869

1.12

0.48

1.1

350.11

270.36

mg/l

0.46

767

Cerebral palsy

1.53

0.48

1.1

208.00

252.13

mg/l

—

Schizoid personality disorder

1.53

0.48

1.0

1.1

222.29

261.50

mg/l

—

Other appendicitis

244

1.23

0.48

1.1

229.13

285.41

mg/l

2.00

210

Diverticular disease of intestine

224

1330

1.08

0.48

1.1

271.60

298.66

mg/l

1.18

205

1161

Seropositive rheumatoid arthritis, wide

681

1.13

0.47

1.1

309.60

263.67

mg/l

0.53

606

Other and unspecified mental retardation

1.48

0.47

1.1

165.81

209.32

mg/l

—

Other menopausal disorders

105

531

1.11

0.47

1.1

218.43

251.64

mg/l

1.25

466

Psoriasis

101

909

1.11

0.47

1.0

1.1

253.55

261.30

mg/l

0.14

799

Tumor necrosis factor alpha inhibitors

616

1.14

0.47

1.1

210.11

251.37

mg/l

1.39

549

Congenital deformities of hip

1.48

0.47

1.2

1.1

123.00

182.97

mg/l

—

Other and unspecified nail disorders

1.46

0.47

1.0

1.1

209.29

225.45

mg/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

364

2316

0.95

0.46

1.1

304.20

271.23

mg/l

1.56

323

2045

Maternal care for cervical incompetence

111

1.35

0.46

1.3

1.1

161.80

237.82

mg/l

—

Gender identity disorders

1.43

0.46

1.0

1.1

228.43

210.89

mg/l

—

Later onset COPD, excluding more controls

189

1.23

0.46

1.0

1.1

309.92

315.57

mg/l

0.06

164

Psoriatic arthropathies

255

1.22

0.45

1.0

1.1

254.65

270.64

mg/l

0.21

218

Viral agents as the cause of diseases classified to other chapters

1.40

0.45

1.0

1.1

240.57

236.00

mg/l

—

Burns and corrosions of external body surface, specified by site

357

1.18

0.44

1.0

1.1

221.28

264.31

mg/l

1.35

309

Benign neoplasm: Liver/bile ducts

1.45

0.44

1.0

1.1

174.80

221.95

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

348

1.18

0.44

1.0

1.1

189.59

204.27

mg/l

0.53

308

Acute nasopharyngitis (common cold)

401

1.17

0.44

1.0

1.1

252.32

283.72

mg/l

1.13

355

Malignant neoplasm of testis, including Hilmo

1.38

0.44

1.0

1.1

272.86

288.00

mg/l

—

Foreign body in ear

1.38

0.44

1.0

1.1

251.57

228.51

mg/l

—

Heart failure,strict

114

884

0.91

0.44

1.1

272.68

323.97

mg/l

1.90

776

Leiomyoma of uterus

247

1312

1.07

0.43

1.1

255.87

237.76

mg/l

0.60

217

1150

Respiratory tuberculosis, confirmed

1.62

0.43

1.2

1.1

259.60

251.92

mg/l

—

COPD

107

794

1.10

0.43

1.1

357.79

310.01

mg/l

0.28

702

Spontaneous abortion

210

1322

1.07

0.42

1.1

222.28

221.60

mg/l

0.02

183

1156

Sequelae of injuries of lower limb

285

1.19

0.42

1.0

1.1

240.35

273.56

mg/l

0.89

248

Superficial injury of ankle and foot

462

1.15

0.42

1.1

236.05

231.36

mg/l

0.07

399

Long labour

109

1023

0.91

0.42

1.0

1.1

204.90

206.13

mg/l

0.05

895

Blood alcohol or alcohol intoxication level

1.43

0.41

1.2

1.1

265.30

267.22

mg/l

—

Other diseases of lip and oral mucosa

145

1339

1.08

0.41

1.1

218.45

257.10

mg/l

3.14

129

1176

Nontoxic diffuse goitre

1.38

0.41

1.3

1.1

204.38

268.92

mg/l

—

Renal agenesis and other reduction defects of kidney

0.00

0.41

0.0

1.1

—

292.67

—

Evidence of alcohol involvement determined by blood alcohol level

1.52

0.41

1.0

1.1

255.20

252.96

mg/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.52

0.41

1.2

1.1

259.60

252.96

mg/l

—

ILD medications: pirfenidone

0.00

0.41

0.0

1.0

—

272.93

—

Ectopic testis

0.00

0.41

0.0

1.1

—

250.60

—

Xanthelasma of eyelid

0.00

0.41

0.0

1.1

—

224.56

—

Mesothelioma

0.00

0.41

0.0

1.1

—

264.38

—

Diseases of arteries, arterioles and capillaries

193

1330

1.07

0.41

1.1

329.98

298.04

mg/l

0.30

162

1174

Allergic urticaria

277

1.19

0.41

1.2

1.1

184.76

245.58

mg/l

2.58

236

Other adrenocortical overactivity

0.00

0.41

0.0

1.1

—

217.71

—

Combined immunodeficiencies

0.00

0.40

0.0

1.0

—

221.18

—

Other vitreous opacities

1.40

0.40

1.0

1.1

243.36

250.14

mg/l

0.10

Abscess of anal and rectal regions

268

1.20

0.40

1.1

293.80

301.06

mg/l

0.05

230

Iron deficiency anaemia secondary to blood loss (chronic)

361

1.16

0.40

1.2

1.1

247.97

267.58

mg/l

0.38

311

Congenital deformities of hip

1.31

0.39

1.1

124.00

183.86

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

306

1.18

0.39

1.1

180.45

206.03

mg/l

1.06

271

Congenital malformations of cardiac chambers and connections

0.00

0.39

0.0

1.0

—

250.53

—

Hernia

384

2457

1.05

0.38

1.1

279.53

277.55

mg/l

0.04

346

2152

Post-traumatic wound infection, not elsewhere classified

1.37

0.38

1.0

1.1

263.56

241.07

mg/l

—

Premature rupture of membranes

105

821

0.91

0.38

1.1

190.29

209.27

mg/l

1.30

718

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

665

1.11

0.38

1.1

307.60

264.06

mg/l

0.47

591

Other disorders of breast and lactation associated with childbirth

1.35

0.38

1.0

195.11

189.47

mg/l

—

Ulcerative colitis (strict definition, require KELA)

618

1.12

0.38

1.0

1.1

223.61

258.85

mg/l

1.75

545

COPD, hospital admissions 3, with asthma pneumonia sepsis

398

1.14

0.38

1.2

1.1

435.81

326.22

mg/l

0.32

348

Postpartum haemorrhage due to anatomy

526

0.87

0.38

1.0

1.1

176.95

193.97

mg/l

0.81

463

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

364

1.15

0.37

1.0

1.1

249.12

270.66

mg/l

0.50

319

In situ neoplasms

114

1049

1.09

0.37

1.1

276.27

253.96

mg/l

0.35

925

Postpartum care and examination

499

1.11

0.37

1.1

188.69

202.16

mg/l

0.65

417

Ovarian hyperstimulation (induction)

1.29

0.36

1.1

191.56

198.70

mg/l

—

Single delivery by forceps and vacuum extractor

501

0.90

0.36

1.1

186.42

204.07

mg/l

0.84

440

Erosion of teeth , including avohilmo

113

1041

1.09

0.36

1.1

254.83

242.13

mg/l

0.18

101

919

All dysplastic lesions of the cervix uteri, vagina or vulva

148

1358

1.07

0.36

1.0

1.1

197.02

208.04

mg/l

0.70

128

1196

Haemorrhagic and haematological disorders of fetus and newborn

1.39

0.36

1.1

156.60

185.11

mg/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

0.63

0.35

1.4

1.1

197.40

235.28

mg/l

—

Other salmonella infections

117

1.28

0.35

1.1

220.60

260.31

mg/l

0.84

Family history of other conditions

1.40

0.35

1.0

1.1

321.17

222.82

mg/l

—

LSIL lesion of the cervix uteri

508

1.12

0.35

1.0

1.1

196.75

203.52

mg/l

0.21

451

Eustachian salpingitis and obstruction

329

1.16

0.35

1.1

270.53

231.34

mg/l

0.69

289

Inguinal hernia

190

1350

0.94

0.35

1.1

304.24

294.35

mg/l

0.22

168

1195

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

566

1.11

0.34

1.0

1.1

246.97

259.21

mg/l

0.23

494

Arthropathic psoriasis

320

1.16

0.34

1.0

1.1

290.19

275.64

mg/l

0.11

277

Thyrotoxicosis

785

1.10

0.34

1.1

252.45

244.59

mg/l

0.14

695

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

680

1.10

0.34

1.0

1.1

219.71

257.25

mg/l

2.02

602

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

604

1.11

0.34

1.0

1.1

224.19

257.20

mg/l

1.56

532

Polyarthritis, unspecified

1.34

0.34

1.1

174.36

279.88

mg/l

2.62

Biguanides

356

2265

0.96

0.33

1.1

306.17

269.15

mg/l

1.51

310

1993

Varicose veins

186

1322

1.06

0.33

1.1

274.57

281.91

mg/l

0.13

159

1157

Alcohol abuse, main dg

539

1.11

0.33

1.2

1.1

223.65

271.10

mg/l

2.61

470

Malignant neoplasm of stomach, including Hilmo

0.67

0.33

1.0

1.1

519.50

268.63

mg/l

—

Type 2 diabetes

428

2405

1.04

0.32

1.1

288.06

262.27

mg/l

1.48

376

2123

Foreign body in alimentary tract

146

1.23

0.32

1.1

178.67

276.32

mg/l

3.21

127

Thyrotoxicosis, other and/or unspecified

626

1.10

0.32

1.1

243.83

244.72

mg/l

0.01

552

Congenital malformations of heart and great arteries

441

1.12

0.31

1.1

223.54

261.17

mg/l

1.33

382

Medical treatment for female infertility

102

1094

0.93

0.31

1.1

181.64

202.37

mg/l

1.56

956

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

478

1.12

0.31

1.1

459.28

286.00

mg/l

1.28

432

Insulin, intermediate and long-acting

182

1671

1.06

0.31

1.1

313.26

281.19

mg/l

1.03

156

1484

Diabetes mellitus

466

2629

1.04

0.30

1.1

288.34

260.34

mg/l

1.53

407

2319

Use of levodopa decarbox-comt-inhibitor

1.30

0.30

2.1

1.1

338.00

281.92

mg/l

—

Major anomalies of jaw size

1.31

0.30

1.2

1.1

173.27

245.59

mg/l

2.59

Melanocytic naevi of other and unspecified parts of face

163

0.80

0.29

1.2

1.1

271.62

255.32

mg/l

0.09

142

Injury of muscle and tendon at lower leg level

439

1.12

0.29

1.0

1.1

306.19

288.75

mg/l

0.27

378

COPD, hospital admissions 1, only main diagnosis

566

0.91

0.29

1.1

403.67

317.23

mg/l

0.29

498

Acute posthaemorrhagic anaemia

1.23

0.29

1.1

254.71

253.39

mg/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

279

1.15

0.28

1.2

1.1

305.04

256.63

mg/l

0.21

243

Atrophic disorders of skin

412

1.12

0.28

1.1

259.28

251.29

mg/l

0.08

361

Other chronic obstructive pulmonary disease

759

1.08

0.27

1.1

366.40

313.16

mg/l

0.29

670

Cyst of Bartholin Gland

116

0.77

0.27

1.1

192.78

216.12

mg/l

—

263

1.14

0.27

1.0

1.1

311.63

300.97

mg/l

0.12

230

Acute appendicitis, with complications

567

1.09

0.26

1.1

433.86

274.67

mg/l

0.92

490

Lactose intolerance

1.28

0.26

1.1

173.91

209.01

mg/l

0.83

Carcinoma in situ of other and unspecified digestive organs

0.69

0.26

1.4

1.1

316.80

264.71

mg/l

—

Other viral hepatitis

225

1.16

0.26

1.1

203.67

268.74

mg/l

2.64

195

Insulin, fast-acting (human)

551

0.91

0.26

1.1

256.58

254.50

mg/l

0.03

489

Non-rheumatic valve diseases

138

940

1.06

0.25

1.1

296.38

298.35

mg/l

0.03

120

832

Other specified disorders of external ear

1.23

0.25

1.1

1.0

203.67

305.97

mg/l

—

COPD related to multimorbidity

634

1.08

0.25

1.1

386.93

319.56

mg/l

0.30

556

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

320

1.13

0.25

1.1

180.45

196.93

mg/l

0.60

282

Postprocedural disorders of digestive system, not elsewhere classified

1.22

0.25

1.1

236.78

261.12

mg/l

—

Insulin medication

219

1763

1.04

0.25

1.1

325.65

272.42

mg/l

1.87

187

1566

Mild mental retardation

1.20

0.25

1.2

1.0

222.78

246.12

mg/l

—

Lactose intolerance, other/unspecified

1.20

0.25

1.1

167.11

208.56

mg/l

—

Pedestrian injured in collision with pedal cycle

1.28

0.24

1.1

208.50

227.93

mg/l

—

Malignant neoplasm of stomach

0.74

0.24

1.0

519.50

269.86

mg/l

—

Presence of cardiac and vascular implants and grafts

685

0.93

0.24

1.1

317.71

331.36

mg/l

0.22

608

Anorexia (incl.atypical)

255

1.14

0.24

1.1

1.0

237.25

212.62

mg/l

0.23

223

Malignant neoplasm of bladder

0.70

0.24

1.2

1.1

228.67

304.48

mg/l

—

Chronic periodontitis, complicated

160

1664

0.95

0.23

1.1

293.14

291.43

mg/l

0.04

142

1465

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

134

1.20

0.23

1.1

514.25

226.64

mg/l

0.55

115

Polyp of the female genital tract

105

641

0.94

0.22

1.0

1.1

249.03

242.88

mg/l

0.10

565

Unspecified maternal hypertension

1.25

0.22

1.0

1.1

160.60

212.84

mg/l

—

Idiopathic thrombocytopenic purpura

1.27

0.22

1.2

1.1

214.00

228.18

mg/l

—

Pervasive developmental disorders excl. Autism + Asperger

1.24

0.22

1.4

1.1

182.60

249.85

mg/l

—

Postmenopausal bleeding

369

0.92

0.21

1.2

1.1

273.35

280.06

mg/l

0.04

322

Chronic respiratory disease originating in the perinatal period

0.00

0.21

0.0

1.1

—

139.60

—

Bilateral cryptorchidism (undescended testicles)

0.00

0.21

0.0

1.1

—

326.90

—

Yaws

0.00

0.21

0.0

1.0

—

236.91

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.1

—

266.40

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.21

0.0

1.1

—

248.18

—

Malaria

0.00

0.21

0.0

1.1

—

259.70

—

Shock, not elsewhere classified

0.00

0.21

0.0

1.0

—

265.91

—

Eating disorders

487

1.09

0.21

1.1

225.34

208.75

mg/l

0.19

421

Congenital aortic valve stenosis

0.00

0.21

0.0

1.1

—

369.25

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.1

—

223.17

—

Mental retardation

125

1.19

0.21

1.2

1.1

198.38

244.19

mg/l

0.70

109

Supervision of normal pregnancy

106

641

0.94

0.21

1.1

196.66

210.58

mg/l

0.65

541

Bursitis of shoulder

1.16

0.21

1.6

1.0

350.20

281.03

mg/l

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.1

—

303.77

—

Acute and transient psychotic disorders

402

1.10

0.20

1.0

1.1

213.04

263.67

mg/l

1.84

349

Other chronic obstructive pulmonary disease, including avohilmo

132

1038

1.05

0.20

1.1

340.21

307.41

mg/l

0.23

111

909

Diabetes, varying definitions

459

2622

1.03

0.20

1.1

288.15

261.10

mg/l

1.43

399

2313

Poor fetal growth

615

1.07

0.20

1.2

1.1

194.67

197.16

mg/l

0.09

545

Pure hyperglyceridaemia

1.25

0.20

1.2

1.0

373.83

270.33

mg/l

—

Other disorders of iris and ciliary body

1.23

0.20

1.2

1.1

281.50

225.63

mg/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

509

1.08

0.20

1.1

228.08

265.33

mg/l

1.69

447

Ventral hernia

614

0.93

0.20

1.1

242.08

279.08

mg/l

0.83

538

Aggressive periodontitis

1.20

0.19

1.0

1.1

330.17

248.11

mg/l

—

Postpartum hemorraghe, all women as controls

123

1270

0.95

0.19

1.1

198.66

201.45

mg/l

0.07

104

1117

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.18

0.19

1.0

407.17

219.07

mg/l

—

Postpartum haemorrhage

123

1086

0.95

0.19

1.1

198.66

204.99

mg/l

0.18

104

947

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

337

1.10

0.19

1.1

268.86

306.60

mg/l

0.97

290

Clear cell adenocarcinoma of kidney

1.24

0.18

1.3

1.0

378.30

255.81

mg/l

—

Benign lipomatous neoplasm

862

1.06

0.18

1.0

1.1

253.23

266.53

mg/l

0.41

761

Eating disorder

424

1.08

0.18

1.1

201.33

201.67

mg/l

0.00

366

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

104

742

0.95

0.18

1.0

1.1

303.10

284.67

mg/l

0.26

661

Labour and delivery complicated by fetal stress [distress]

135

923

0.96

0.17

1.1

190.80

197.71

mg/l

0.27

120

800

All dysplastic lesions of the cervix uteri

131

1244

1.04

0.17

1.1

193.53

203.84

mg/l

0.62

112

1096

Lesion of sciatic nerve

1.15

0.17

1.0

1.1

378.43

250.69

mg/l

—

Malignant neoplasm of prostate, including Hilmo

350

1.07

0.17

1.1

323.47

340.16

mg/l

0.22

315

Malignant neoplasm of cervix uteri, including Hilmo

1.13

0.17

1.0

203.86

195.65

mg/l

—

Cutaneous abscess, furuncle and carbuncle

942

1.05

0.17

1.1

270.44

251.23

mg/l

0.56

831

Campylobacter enteritis

1.11

0.17

1.0

1.1

290.29

228.02

mg/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

679

1.06

0.17

1.1

236.15

245.61

mg/l

0.17

601

HSIL lesion of the cervix uteri, vagina or vulva

904

1.05

0.17

1.0

1.1

195.85

206.19

mg/l

0.50

791

Chronic viral hepatitis

196

1.12

0.16

1.1

207.59

257.29

mg/l

1.50

167

Benign neoplasm of thyroid gland

1.14

0.16

1.1

286.75

225.40

mg/l

—

Non-ischemic cardiomyopathy

539

0.94

0.16

1.0

1.1

263.55

313.46

mg/l

1.36

471

Idiopathic urticaria

1.13

0.16

1.3

1.1

223.13

223.00

mg/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

254

1.10

0.16

1.3

1.1

296.00

293.01

mg/l

0.02

218

Coxarthrosis, primary, with hip surgery

941

0.95

0.15

1.1

301.78

304.36

mg/l

0.05

830

Paralytic ileus

0.78

0.15

1.2

1.1

279.17

291.55

mg/l

—

Endovascular or surgical operations to intracerebral aneurysms

130

1.15

0.15

1.0

217.33

311.93

mg/l

2.07

114

Atrial septal defect, secundum type

1.19

0.15

1.2

1.1

183.00

222.88

mg/l

0.62

Basal cell carcinoma, including avohilmo

107

705

1.05

0.15

1.1

388.00

286.80

mg/l

0.69

627

malignant neoplasm of male genital organs

373

1.06

0.15

1.0

1.1

352.00

336.00

mg/l

0.18

331

Diabetes medication

442

2674

0.98

0.15

1.1

291.21

261.98

mg/l

1.55

386

2356

Femoral hernia

1.13

0.15

1.0

1.1

173.89

243.00

mg/l

—

Fracture of femur

428

0.93

0.15

1.0

1.1

307.31

305.71

mg/l

0.01

370

Complications associated with artificial fertilization

1.10

0.15

1.1

1.0

191.56

200.99

mg/l

—

Calcific aortic valvular stenosis, operated

435

1.07

0.15

1.0

1.1

276.51

328.14

mg/l

1.03

379

Calcific aortic valvular stenosis

435

1.07

0.15

1.0

1.1

276.51

328.14

mg/l

1.03

379

Operations 2 for CAVS

435

1.07

0.15

1.0

1.1

276.51

328.14

mg/l

1.03

379

Calcific aortic valvular stenosis, diagnosis (helper)

435

1.07

0.15

1.0

1.1

276.51

328.14

mg/l

1.03

379

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

606

1.06

0.14

1.0

1.1

251.45

257.11

mg/l

0.10

528

Seropositive rheumatoid arthritis, strict definition

368

0.92

0.14

1.1

224.39

263.89

mg/l

0.94

322

COPD, hospital admission 2, with asthma infections

519

1.06

0.14

1.1

413.96

317.20

mg/l

0.33

456

Calcific aortic valvular stenosis, including rheumatic fever

436

1.07

0.14

1.0

1.1

276.51

328.14

mg/l

1.03

379

Haemorrhage in early pregnancy

126

1183

1.04

0.13

1.1

209.11

211.98

mg/l

0.07

117

1031

Combinations of oral blood glucose lowering drugs

705

0.95

0.13

1.0

1.1

397.24

311.12

mg/l

0.87

629

Contusion of ankle

128

0.86

0.13

1.1

285.45

223.98

mg/l

0.39

109

Myocardial infarction, without ST-elevation

687

1.05

0.13

1.1

315.80

317.60

mg/l

0.03

605

Mental retardation, wide definition

131

1.14

0.13

1.2

1.1

198.38

242.94

mg/l

0.69

114

Suppurative and necrotic conditions of lower respiratory tract

117

0.85

0.13

1.1

1.0

304.20

296.37

mg/l

—

102

Seborrhoeic keratosis

481

1.06

0.13

1.1

348.83

291.15

mg/l

0.47

423

Total colectomy operation

110

0.82

0.13

1.0

1.1

224.44

265.28

mg/l

—

Total colectomy

110

0.82

0.13

1.0

1.1

224.44

265.28

mg/l

—

Pacemaker

547

0.95

0.13

1.0

1.1

282.23

319.77

mg/l

0.73

477

385

1.06

0.12

1.1

308.83

313.71

mg/l

0.07

335

1.17

0.12

1.0

1.1

334.36

243.37

mg/l

0.44

Valvular heart disease excluding rheumatic fever

138

965

1.03

0.12

1.1

296.38

295.15

mg/l

0.02

120

855

Primary coxarthrosis, bilateral

561

1.05

0.12

1.1

334.92

302.08

mg/l

0.54

497

Diabetes mellitus in pregnancy

182

1134

1.03

0.12

1.1

199.17

202.42

mg/l

0.11

167

984

Hernia of abdominal wall

136

1402

0.97

0.11

1.1

271.93

288.47

mg/l

0.23

119

1248

Subarachnoid haemorrhage

201

1.09

0.11

1.0

297.77

284.29

mg/l

0.11

175

Toxic effect of ethanol

126

0.87

0.11

1.0

1.1

180.45

273.96

mg/l

1.70

104

Peripheral artery operations in Hilmo

219

0.91

0.11

1.1

744.27

324.33

mg/l

0.45

187

Maternal care for known or suspected abnormality of pelvic organs

122

857

0.97

0.11

1.1

184.60

216.50

mg/l

3.04

106

749

Childhood allergy (age < 16)

674

1.04

0.11

1.1

207.04

222.78

mg/l

0.27

590

475

1.05

0.10

1.0

1.1

191.48

194.94

mg/l

0.10

420

Other (not insulin) diabetes medications

382

2303

0.98

0.10

1.1

294.29

267.60

mg/l

1.38

337

2029

Coxarthrosis, primary

143

1178

1.03

0.10

1.1

302.80

302.96

mg/l

0.00

124

1036

Pre-eclampsia or eclampsia

879

1.04

0.10

1.2

1.1

201.94

214.71

mg/l

0.62

766

Basal cell carcinoma

101

676

1.03

0.10

1.0

1.1

400.92

286.38

mg/l

0.76

602

Other Crohn's disease

251

1.08

0.10

1.0

1.1

213.40

273.64

mg/l

1.29

217

Solid cancers, helper endpoint

329

1974

0.98

0.09

1.1

343.69

259.21

mg/l

1.42

284

1737

Viral haemorrhagic fevers, not elsewhere classified/unspecified

493

0.95

0.09

1.2

1.1

327.31

263.89

mg/l

0.92

426

Pre-eclampsia or poor fetal growth

146

1419

1.03

0.09

1.2

1.1

199.49

207.00

mg/l

0.44

130

1240

Cleft lip, lip and palate or palate

1.06

0.09

1.0

1.1

302.00

211.49

mg/l

—

Coxarthrosis

133

855

1.03

0.09

1.1

297.29

302.47

mg/l

0.11

114

740

Macular cyst

1.04

0.09

1.0

1.1

306.60

227.17

mg/l

—

Inguinal hernia, unilateral

1.11

0.09

1.0

1.1

164.67

232.98

mg/l

—

Inguinal of femoral hernia, unilateral

1.11

0.09

1.0

1.1

164.67

232.98

mg/l

—

Femoral hernia, unilateral

1.11

0.09

1.0

1.1

164.67

232.98

mg/l

—

Type 2 diabetes, strict (exclude DM1)

377

2244

0.99

0.08

1.1

293.98

266.86

mg/l

1.38

334

1979

Type 1 diabetes, wide definition, subgroup 1

846

0.97

0.08

1.1

289.39

248.62

mg/l

0.62

756

Personal history of malignant neoplasm

165

1.09

0.08

1.2

1.1

162.81

237.13

mg/l

1.65

146

Lichen ruber planus, wide definition including periferal and oral lichen planus

573

0.96

0.08

1.0

1.1

296.88

270.03

mg/l

0.29

500

COPD, early/later onset

810

1.03

0.08

1.1

366.40

315.14

mg/l

0.28

710

Serous carcinoma of ovary, including Hilmo

0.81

0.08

1.0

415.80

235.85

mg/l

—

Maxillary retrognathism

0.77

0.08

1.0

1.1

172.20

237.30

mg/l

—

Benign mammary dysplasia

332

1.05

0.08

1.1

322.10

241.16

mg/l

0.64

291

Obstructed labour due to malposition and malpresentation of fetus

108

1033

0.97

0.08

1.0

1.1

241.68

207.05

mg/l

0.41

903

Periodontal disease, other/unspecified

1.05

0.08

1.3

1.1

301.57

255.59

mg/l

—

Lichen planus, including avohilmo

480

0.96

0.08

1.0

1.1

318.85

274.73

mg/l

0.44

414

Malignant neoplasm of prostate

328

1.04

0.07

1.1

344.52

339.27

mg/l

0.05

296

Malignant neoplasm of mesothelium and soft tissue

0.86

0.07

1.3

1.1

287.83

238.84

mg/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

140

1145

0.98

0.07

1.1

339.94

301.74

mg/l

0.58

128

1006

Other assisted single delivery

1.08

0.07

1.0

178.25

197.63

mg/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

935

0.97

0.07

1.1

309.10

285.49

mg/l

0.43

820

Glucagon-like peptide-1 (GLP-1) analogues

935

0.97

0.07

1.1

309.10

285.49

mg/l

0.43

820

Other disorders of amniotic fluid and membranes

681

1.03

0.07

1.0

1.1

205.60

207.84

mg/l

0.07

595

Graves disease, strict definition

343

1.05

0.07

1.2

1.1

239.52

229.36

mg/l

0.11

303

Other acute skin changes due to ultraviolet radiation

0.87

0.07

1.3

1.1

188.86

244.90

mg/l

—

Benign neoplasm: Rectosigmoid junction

0.86

0.07

1.1

241.43

258.86

mg/l

—

Pre-eclampsia

827

1.03

0.07

1.2

1.1

204.34

214.31

mg/l

0.42

723

Foreign body on external eye

501

1.04

0.07

1.1

418.39

293.87

mg/l

0.38

440

Type 1 diabetes, wide definition

872

0.97

0.07

1.1

285.39

248.25

mg/l

0.58

780

Struck by thrown, projected or falling objec

163

0.92

0.07

1.1

217.40

276.37

mg/l

—

142

Respiratory and cardiovascular disorders specific to the perinatal period

0.87

0.07

1.0

1.1

462.88

217.73

mg/l

—

Rubella [German measles]

0.87

0.06

1.0

1.1

336.63

330.79

mg/l

—

Pyothorax

0.87

0.06

1.1

1.0

327.13

302.34

mg/l

—

Tooth eruption problems

683

0.97

0.06

1.1

177.24

215.94

mg/l

2.32

594

HSIL lesion of the cervix uteri

858

1.03

0.06

1.0

1.1

194.84

205.17

mg/l

0.46

753

Benign neoplasm of ovary

433

1.04

0.06

1.0

1.1

325.33

233.26

mg/l

0.78

387

COPD, hospital admissions

809

1.02

0.06

1.1

365.63

315.97

mg/l

0.27

709

Gonarthrosis, primary, with knee surgery

136

1062

1.02

0.06

1.1

262.63

318.07

mg/l

2.89

115

931

Squamous cell neoplasms and carcinomas of the skin

109

1.10

0.06

1.1

479.58

304.18

mg/l

0.44

Other abnormal uterine and vaginal bleeding

523

1.03

0.06

1.1

1.0

221.21

229.18

mg/l

0.23

458

Maternal care for other known or suspected fetal problems

133

827

1.02

0.05

1.1

182.97

206.68

mg/l

2.06

110

722

Impacted teeth

101

917

0.98

0.05

1.1

201.75

219.22

mg/l

0.74

803

Pedal cyclist injured in transport accident

821

1.02

0.05

1.1

230.65

257.76

mg/l

1.02

724

Major coronary heart disease event excluding revascularizations

162

1063

1.02

0.05

1.1

303.40

321.50

mg/l

0.41

142

940

Congenital malformations of ovaries, fallopian tubes and broad ligaments

218

1.06

0.05

1.1

330.06

204.08

mg/l

0.35

191

Fracture of forearm

202

1827

1.01

0.05

1.1

271.45

262.14

mg/l

0.19

166

1613

Type 2 diabetes, definitions combined

377

2232

0.99

0.05

1.1

292.01

266.94

mg/l

1.24

333

1972

Abrasion of teeth

114

1160

0.98

0.05

1.1

247.09

252.08

mg/l

0.11

1019

Other blood glucose lowering drugs, excl. Insulins

323

0.96

0.05

1.1

329.36

299.96

mg/l

0.31

284

Benign neoplasm of middle ear and respiratory system

179

1.06

0.05

1.1

1.0

326.08

294.28

mg/l

0.23

153

Fracture of shoulder and upper arm

109

1070

1.02

0.04

1.1

257.84

260.15

mg/l

0.05

949

malignant neoplasm of female genital organs

306

1.04

0.04

1.0

1.1

290.67

245.45

mg/l

0.43

272

Postpartum hemorraghe, parous women as controls

123

1062

0.99

0.04

1.1

198.66

200.93

mg/l

0.06

104

936

Carcinoma in situ of cervix uteri

422

0.97

0.03

1.0

1.1

193.78

208.22

mg/l

0.39

374

Injury of unspecified body region

200

1.05

0.03

1.0

1.1

239.06

270.85

mg/l

0.40

171

Pregnancy examination and test

537

1.02

0.03

1.1

192.23

205.36

mg/l

0.60

449

Obstructed labour due to maternal pelvic abnormality

428

1.03

0.03

1.1

223.08

234.12

mg/l

0.29

375

Crohn's disease of large intestine

169

0.95

0.03

1.0

1.1

231.80

265.15

mg/l

—

144

Injuries to unspecified part of trunk, limb or body region

290

0.97

0.03

1.0

1.1

228.09

266.68

mg/l

0.75

248

Benign neoplasm of breast

330

0.97

0.03

1.2

1.1

250.93

226.63

mg/l

0.27

290

Haemangioma, any site

231

1.04

0.02

1.0

1.1

198.21

271.26

mg/l

2.97

202

D07AA Corticosteroids, weak (group I)

608

1.02

0.02

1.0

1.1

224.93

236.20

mg/l

0.21

534

Failed induction of labour

299

0.97

0.02

1.1

191.61

201.46

mg/l

0.26

260

Type 2 diabetes, definitions combined, including avohilmo

386

2257

1.00

0.02

1.1

290.75

265.28

mg/l

1.29

341

1991

Supervision of high-risk pregnancy

104

619

1.01

0.02

1.1

231.83

210.63

mg/l

0.21

522

Wet age-related macular degeneration

211

0.97

0.02

1.2

1.1

319.33

296.47

mg/l

0.29

184

Complications of labour and delivery

272

1506

1.00

0.01

1.1

218.73

221.12

mg/l

0.10

241

1305

Postmenopausal atrophic vaginitis

409

1.01

0.01

1.1

259.26

273.61

mg/l

0.18

353

Other or unspecified ileus, impaction or obstruction

403

1.02

0.01

1.1

279.70

309.55

mg/l

0.52

345

Psoriasis vulgaris

573

1.01

0.01

1.1

270.57

265.01

mg/l

0.06

502

Abnormal spermatozoa

224

1.03

0.00

1.0

1.1

419.24

351.56

mg/l

0.35

199

Maternal care for known or suspected fetal abnormality and damage

719

1.00

0.00

1.1

180.78

207.56

mg/l

2.02

629

Arthropod-borne viral fevers and viral haemorrhagic fevers

551

1.00

0.00

1.2

1.1

310.57

264.74

mg/l

0.67

480

Pedal cyclist injured in other and unspecified transport accidents

368

1.01

0.00

1.1

246.67

268.27

mg/l

0.28

317

Coronary atherosclerosis

178

1126

1.00

0.00

1.1

297.15

319.75

mg/l

0.55

146

994

Viral hepatitis

256

1.02

0.00

1.1

203.67

270.49

mg/l

2.85

220

Embedded and impacted teeth

142

1174

1.00

0.00

1.1

200.09

230.10

mg/l

1.59

127

1033

Benign neoplasm: Skin, unspecified

102

0.98

0.00

1.2

1.1

462.90

256.52

mg/l

—

Extreme obesity with alveolar hypoventilation

102

0.98

0.00

1.0

1.1

269.00

255.34

mg/l

—

Artificial opening status

122

0.98

0.00

1.3

1.1

259.67

316.31

mg/l

0.61

105

Congenital malformations of genital organs

398

1.00

0.00

1.1

273.45

219.44

mg/l

0.30

352

Postpartum haemorrhage due to retained placenta

537

1.01

0.00

1.1

194.05

203.00

mg/l

0.28

477

Other malignant neoplasms of skin (=non-melanoma skin cancer)

102

698

1.00

0.00

1.0

1.1

392.89

288.11

mg/l

0.70

622

Contact with machinery

291

1.00

0.00

1.2

1.1

358.83

317.12

mg/l

0.39

249

Psoriatic arthropathies, ICD10

309

1.00

0.00

1.0

1.1

254.65

280.02

mg/l

0.38

268

Haemangioma and lymphangioma, any site

252

0.99

0.00

1.0

1.1

197.90

273.64

mg/l

3.23

219

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.0

1.1

—

202.11

—

Other and unspecified disease of Bartholin gland

0.86

0.00

1.2

1.1

208.60

229.56

mg/l

—

Deaf mutism, not elsewhere classified

0.00

0.0

1.1

—

321.75

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.0

—

205.20

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.0

1.1

—

262.29

—

Benign neoplasm: Ciliary body

0.00

0.0

1.1

—

259.88

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.1

—

278.14

—

Crushing injury of hip and thigh

0.00

0.0

1.0

—

235.80

—

Macrocephaly

0.00

0.0

1.0

—

166.00

—

Absence of one kidney

0.00

0.0

1.1

—

160.63

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

305.12

—

Other rupture of muscle

0.00

0.0

1.2

—

252.00

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.94

0.00

1.0

1.1

237.60

220.20

mg/l

—

Diphtheria

0.00

0.0

1.0

—

260.00

—

Plasmodium falciparum malaria

0.00

0.0

1.2

—

263.33

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.1

—

238.13

—

Other renal tubulo-interstitial diseases

0.94

-0.00

1.0

292.83

231.70

mg/l

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.1

—

165.33

—

Shigellosis

0.00

-0.00

0.0

1.2

—

338.20

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.2

—

206.40

—

Congenital glaucoma

0.00

-0.00

0.0

1.0

—

154.20

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.0

—

222.20

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.1

—

230.89

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.2

—

189.50

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.0

—

147.80

—

Microtia (small ears)

0.00

-0.00

0.0

1.0

—

146.00

—

Cystic kidney disease

0.99

-0.00

1.0

1.1

422.88

253.66

mg/l

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.0

—

262.50

—

Hirsprung

0.00

-0.00

0.0

1.0

—

452.60

—

Ankylosis of teeth

0.00

-0.00

0.0

1.3

—

244.00

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.0

—

139.83

—

Other disorders following mastoidectomy

0.00

-0.00

0.0

1.2

—

275.00

—

Mechanical strabismus

0.00

-0.00

0.0

1.2

—

227.83

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

1.0

—

263.75

—

Senility

0.00

-0.00

0.0

1.0

—

176.20

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

1.2

—

310.20

—

Injury of muscle and tendon at forearm level

1.02

-0.00

1.0

1.1

236.20

279.00

mg/l

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.1

—

285.29

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

262.60

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

202.00

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.0

—

148.11

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.2

—

338.40

—

Pedal cyclist injured in collision with motor vehicle

0.94

-0.00

1.0

1.1

198.67

262.32

mg/l

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.1

—

352.11

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

278.80

—

Thyroid crisis or storm

0.00

-0.00

0.0

1.1

—

274.25

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.1

—

245.71

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.0

—

154.80

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

1.0

—

245.75

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.1

—

248.29

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

252.00

—

Alpha thalassaemia

0.00

-0.00

0.0

1.0

—

211.20

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.0

—

95.50

—

Hypergammalglobulinemia, unspecified

0.00

-0.00

0.0

1.0

—

228.00

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

1.0

—

231.29

—

Other specified disorders of kidney and ureter

1.01

-0.00

1.1

1154.00

237.48

mg/l

—

Otorrhoea

0.00

-0.00

0.0

1.0

—

161.88

—

Nezelof syndrome

0.00

-0.00

0.0

1.0

—

210.86

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.1

—

292.75

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.0

—

266.40

—

Chondrosarcoma

0.00

-0.00

0.0

1.0

—

213.83

—

0.92

-0.00

1.1

191.25

202.07

mg/l

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.2

—

188.20

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.0

—

226.83

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

289.83

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

328.00

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.1

—

270.38

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.1

—

262.57

—

Noninfective disorders of pinna

0.00

-0.00

0.0

1.0

—

239.29

—

Profound mental retardation

0.00

-0.00

0.0

1.0

—

198.17

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

1.2

—

282.40

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.0

—

284.00

—

Chronic thyroiditis

0.00

-0.00

0.0

1.0

—

233.14

—

Paget disease

0.00

-0.00

0.0

1.0

—

246.11

—

Benign neoplasm: Skin of scalp and neck

0.89

-0.00

1.0

437.00

228.13

mg/l

—

Benign neoplasm: Skin of trunk

0.91

-0.00

1.0

1.1

173.51

253.95

mg/l

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.0

—

300.60

—

Umbilical hernia

850

1.00

-0.00

1.1

282.18

295.84

mg/l

0.12

750

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

258.60

—

0.92

-0.00

1.1

185.00

195.17

mg/l

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

1.0

—

172.50

—

Pterygium

0.93

-0.00

1.2

1.1

326.00

274.45

mg/l

—

Qualitative platelet defects

0.00

-0.00

0.0

1.1

—

248.29

—

Folliculitis decalvans

0.00

-0.00

0.0

1.2

—

331.17

—

Cystic fibrosis

0.00

-0.00

0.0

1.0

—

185.83

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.0

—

228.38

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.1

—

264.57

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

293.43

—

Mixed hyperlipidaemia

0.96

-0.00

1.3

1.0

248.00

296.86

mg/l

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

287.88

—

Erythema multiforme

0.88

-0.00

1.2

1.1

253.20

228.79

mg/l

—

Diphtheria

0.00

-0.00

0.0

1.0

—

260.00

—

Cystic kidney disease

0.93

-0.00

1.0

1.1

409.00

251.88

mg/l

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.0

—

190.40

—

Absence of one kidney

0.00

-0.00

0.0

1.1

—

158.00

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

1.1

—

246.57

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

303.80

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

283.00

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

98.52

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

1.0

—

174.67

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.0

—

207.80

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS